Archive for the ‘Genetic Testing’ Category

The research report on the Direct-to-consumer Genetic Testing market leverages iterative and comprehensive research methodology to deliver insights regarding the current market scenario over the study timeframe. The report dives deep into the development trends that will influence the behavior of the Direct-to-consumer Genetic Testing + market in the forthcoming years. Moreover, other key pointers such as the regional characteristics and policies governing the industry are highlighted in the research. Apart from this, the study incorporates the impact of the COVID-19 pandemic on the revenue share and annual growth rate of the industry.

A new report on Direct-to-consumer Genetic Testing market that provides a comprehensive review of this industry with respect to the driving forces influencing the market size. Comprising the current and future trends defining the dynamics of this industry vertical, this report also incorporates the regional landscape of Direct-to-consumer Genetic Testing market in tandem with its competitive terrain.

The market analysis showcases the vast research on the product terrain which is inclusive of the advantages and disadvantages of the products developed by the various manufacturers. Besides this, an investigation of the evolution of the competitive dynamics along with details pertaining to raw material supply chain and downstream buyers are presented in the report.

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/169156

A gist of the competitive landscape of the Direct-to-consumer Genetic Testing market:

An outline of the regional scope of the Direct-to-consumer Genetic Testing market:

Global Direct-to-consumer Genetic Testing Market Segmentation:This market has been divided into Types, Applications, and Regions. The growth of each segment provides an accurate calculation and forecast of sales by Types and Applications, in terms of volume and value for the period between 2020 and 2026. This analysis can help you expand your business by targeting qualified niche markets. Market share data is available on the global and regional level.

Additional takeaways from the Direct-to-consumer Genetic Testing market report:

Highlights points of Direct-to-consumer Genetic Testing Industry:

Key questions answered in the report:

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/169156

More here:
Direct-to-consumer Genetic Testing Market Research Growth by Manufacturers, Regions, Type and Application, Forecast Analysis to 2025 - Express Journal

Many countries have never experienced a major oil spill. The critical steps taken in the early days ... [+] can make all the difference to the cleanup that may be needed for decades to come.

Major oil spills, like what happened on the Indian Ocean Island of Mauritius last Thursday, are unfortunately more common than they should be.

Years of forcing the global shipping industry to increase sustainability and safety standards have not yielded sufficient results, as international shipping continues to lag behind on climate change commitments.

This has placed many smaller nations, without the resources to handle a major oil incident, woefully unprepared to deal with the complexity and magnitude of how to handle major industrial oil spill, as Mauritius found to its cost last week. As an aging and abandoned large crude oil tanker off the coast of Yemen is also at risk of spilling across the entire Red Sea, causing the US Secretary of State to issue an alert, what steps do countries have to take if a major oil spill hits their shores for the first time?

What happens when there is an oil spill and what steps should a country take, particularly if theyve never experienced such an event.

It all eventually boils down to two questions.

A bi-partisan US Congress hosts a hearing in 2007 on the Cosco Busan Heavy Fuel Oil spill in San ... [+] Francisco Bay during the Independent Accident Investigation as well as Natural Resources Damage Assessment - key tools to conducting any meaningful inquiry.

After all is said and done, oil cleanup operations come down to two questions: who pays, and how much do they pay. Some key early decisions could mean an order of magnitude (ten times) difference in any payout. This is critical to know.

All major shipping companies pay into catastrophic risk insurance. Ultimately, any funds for restoration of habitats will come from this pooled risk insurance that has pockets of billions of dollars. As a comparison, compensation for the Deepwater Horizon oil spill in 2010, which had a robust scientific assessment behind it, was $20 billion, for Exxon Valdez oil spill in 1989 it was $5 billion (over $10.5 billion in todays prices). If bilateral settlement terms for what is a reasonable cost of cleanup cannot be reached, this will often go to arbitration. This is a well understood process.

At such arbitration, the quality of the data collected in the early days of the incident will make all the difference in the decision of the magnitude of payout made.

Here are the five critical steps that any country experiencing an oil spill must take in the immediate days following a crisis.

Salvage teams work on containment of oil as well as ensuring the stability of the vessel during the ... [+] initial Containment phase.

There are two aspects to this: containing the oil spill itself, and salvaging the vessel. This often entails two different sets of experts for each challenge.

A key group of international technical experts in suggesting effective spill response techniques to a maritime incident is ITOPF. They are usually activated by a vessels owner and insurer. They may organize a spill response team, such as Oil Spill Response Limited, which are the largest international industry-funded cooperative that exists to respond to oil spills wherever in the world they may occur, by providing preparedness, response and intervention services. They are wholly owned by most of the environmentally responsible oil and gas companies, who employ 275 people across 12 locations around the world. They also respond to spills for non-members, subject to a set of pre-set fees.

They are the teams who advise and lead on the initial operational details of containing the oil spill, including at distances far from the actual accident site itself.

In cases where vessels have been structurally impacted, the experts are typically the large, global, salvage companies who are appointed by the ships owners and insurers.

Proper scientific protocols must be followed to ensure any evidence collected can be admitted into ... [+] the investigation, for example using gloves, and correctly documenting and storing samples following an approved chain of custody.

Whilst in many countries there is often the initial shock, confusion and coordination challenges in the immediate aftermath of a spill, the samples collected in the immediate days following a spill (and continually in the following days and weeks), will be the biggest determination of any cleanup compensation payout.

No resource should be spared collecting these samples using the right scientific protocols that would be admissible in any arbitration. The pay off from extensive and well cataloged samples could mean the difference of a payout that is orders of magnitude (ten times) greater, and would justify any investment in the collection team and robust scientific protocols that could be admissible in any arbitration.

Once this window is missed, it may be too late to see the full extent of the damage caused, as lessons from the quality of sampling around the Cosco Busan show.

Biological samples (such as coral, fish, mangrove tissue) can reveal certain bio-markers of where the pollution may have traveled that is invisible to the naked eye or satellite evidence. To obtain these indicators, specimens need to be genetically tested using specialist genomic equipment that is widely available in the US and Europe.

SAR Satellite imagery reveals that the oil spill had drifted as far as Ile aux Cerfs by Tuesday ... [+] August 11 2020., 14 miles North of the crash site due to the heavy winds along the East Coast (this is a major kite surfing zone). This type of data may not be visible to the naked eye, but can help track the potential genetic marking impact of the spill.

Often such equipment is not present in the location of the spill and there is a several week delay for this to arrive (especially given Covid-19). However, this does not mean samples should not be collected daily from specific locations under specific protocols. These samples can be frozen and tested many weeks or months later when the right equipment arrives.

Incidentally, due to Mauritius strong response to Covid-19 (there are no local cases), many PCR kits are currently available which may end up being one of the most powerful tools in the oil spill response. That, combined with armies of specially trained volunteers from the tourism and fishing community who know the area, could give a strong advantage for a unified a national response.

The US Agency responsible for environmental impact assessments after a major oil spill, NOAA, offers ... [+] guidance to countries on how to best conduct such assessments, including the document templates to accurately log all specimens and samples that are collected.

What is most important for samples to be admitted in any arbitration settlement is the strict cataloging of the chain of custody and storage of the samples. The importance of this cannot be emphasized enough. Many cases have fallen apart when it was alleged that samples could have been tampered with.

Fortunately, Mauritius has a large and secure tuna industry and aquaculture facilities with refrigeration and security capacity that should address these concerns.

The documentation and protocols can be printed off from existing documentation, such as on Page 23 of NOAAs guide to Heavy Fuel Oil spills. Often a swift training is required for all collecting officers. Given the large local fishing and tourism sector around the crash location, Mauritius has the opportunity to secure and freeze a much more compelling set of baseline data than many other countries. Especially given how well studied and monitored the wildlife sanctuaries around the crash site were.

When major oil spill or mining accidents occur, there is often anger and confusion. Whilst there is ... [+] a process to determine what happened, a completely separate and de-politicized process should be run in parallel to get the world's best, independent scientific experts to conduct an extensive Natural Resource Damage Assessment. Image of protests at Brazilian Mining Giant, Vale, following a mining accident in 2019.

There is often a fog of war after a major oil spill, particularly where this happens in a country for the first time. It took two major oil spills (1969 Santa Barbara, California and 1989 Exxon Valdez) for the US to fully have its standard operating protocols and laws in place, so they could better handle the Cosco Busan in San Francisco Bay in 2007.

In most countries, there is often inter-departmental challenges. In the US, following major oil spills, the Port Authorities are often at odds with the Environmental Agencies (EPA and NOAA). However, in the most effective cases, they are put under the umbrella of the US Department of Justice to ensure a coordinated response with sufficient and fast-tracked funds, to ensure the best possible outcome for the citizens of the affected area.

Whilst there may initially be trade-offs between who pays for sample collections, scientific information, and other baseline impact studies, resourcing should be agreed in a unified way. In the United States, there are often well established established Accident Investigation Boards for major events that look into the forensics of the incidents and lessons learned. Such processes into the causes of what happened should be handled separately from preparing a strong and independent Natural Resource Damage Assessment case for compensation from any polluter.

Countries should engage their own, independent oil spill experts to assess the damage to the Natural ... [+] Resources. This team will be responsible for independently deciding sample location and overseeing the sample collection and storage process.

These should be separate from those provided by the polluting company, the insurer or any host nation associated with a polluter

This is critical. Given the magnitude in any payout, not all international experts are incentivized to offer objective advice. In many cases, it may be more prudent for the insurer to have a counter-narrative to diminish the potential impact (e.g., describing an environment that was already in decline, tourism was impacted by Covid-19 or that multiple factors were to blame, rather than what the insurer is responsible for).

Where a country has its own set of independent experts who have gone through major oil spills before, these countries are always more effectively prepared with a stronger, unified narrative. Given that settlements are often in the hundreds of millions of dollars and even billions of dollars, there are very high stakes here to have the right, independent experts on the side of the country and citizens who have been impacted.

A world class science team will ensure appropriate security and storage of all samples from as wide ... [+] a location as possible, to be admissible in any Natural Resources Damages Assessment

The centerpiece of any claim will come down to the credibility of the science presented. This will be determined by the quality of the samples and data collected (including how strictly scientific protocols were carried out and the extensiveness of the tests), as well as the quality of the experts engaged.

Often, a polluter or host nation would offer to pay for a scientific team. This could lead to sub-optimal outcomes for the host nation. Not all scientists are equal, and each may use different approaches to reduce their assessment of impact.

One example that has been seen in many places is for a scientist to cut fish into slices to visually look for the presence of oil as the main indicator. Whilst this makes for compelling media images, this does not give robust scientific information. When a fish takes in oil, it is akin to a human drinking alcohol. The liver de-toxifies (reduces the toxicity) of the alcohol. The only way to accurately assess the impact of an oil spill is through advanced genetic testing.

There is a specific gene that is sought for in genetic testing and that is the famous CYP1A gene (part of the family of CYP enzymes). This is a critical indicator in response to oil spills. This is a well known bio-marker that indicates the fish defense mechanisms have been activated against the pollution. If more of this enzyme is made, that may be an indicator that the fish trying to detoxify itself, as admissible evidence of stress due to the oil spill. This is the true measure to understand the impact of an oil spill (not visual inspection of a slice of fish), which reveals that oil spills are often the invisible killer to marine life. These bio-markers can easily be detected using PCR tests, that are commonly being used for Covid-19 testing.

The output from DNA results will look like a series of lines. Experts will know how to read these ... [+] and search for the CYP1A class of gene that indicates stress from oil pollution, and can be detected from PCR Kits.

Hence it is important that any country impacted agree swiftly on an international scientific team from an internationally respected university who can work with local scientists to jointly frame the right questions and focus immediately on collecting the right samples. With Exxon Valdez in Alaska, only a certain set of species population needed to be monitored. With more biodiverse areas, experts in animal diseases from corals, mangroves, birds, turtles, insects, dolphins, whales, crustaceans, plants, flowers and trees would need to be engaged to know which indicators to start searching for. Some of the worlds leading scientists who worked on behalf of the communities that secured the $20 billion settlement from BP from the Deepwater Horizon well blowout, are at Stanford Universitys Marine Hopkins Laboratory in California. They also happen to have some of the worlds deepest expertise in the Indian Ocean, covering coral reefs, fish and other rare marine life found only in the Indian Ocean.

If the funding party (the polluter or their sponsoring nation) does not agree to a highly credible, world class scientific team from a separate country, it is often prudent for the host Government to pay for this scientific expertise themselves and be reimbursed later during any settlement. These costs may be as high as $3 million initially for the full range of scientific logging, right equipment, and expertise that a world class scientific team can oversee and evaluate the samples being collected, working and training local scientists to build capacity long after the international scientists have left.

Bearing in mind that the Cosco Busans settlement was $44m for a spill that was in the heavily industrial San Francisco Bay three and a half times smaller than the Wakashio in Mauritius and significantly smaller than the risk from theSafer tanker off the coast of Yemen and the environmentally sensitive Red Sea with some of the last remaining Pristine Corals, the investment in the right internationally renown scientific team early on could immensely strengthen any case during arbitration.

Link:
The Critical First Five Steps Every Country Should Take When Responding To A Major Oil Spill - Forbes

LOS ANGELES, United States: QY Research has recently published a report, titled Global Breast Cancer Predictive Genetic Testing Market Size, Status and Forecast 2020-2026. The research report gives the potential headway openings that prevails in the global market. The report is amalgamated depending on research procured from primary and secondary information. The global Breast Cancer Predictive Genetic Testing market is relied upon to develop generously and succeed in volume and value during the predicted time period. Moreover, the report gives nitty gritty data on different manufacturers, region, and products which are important to totally understanding the market.

Key Companies/Manufacturers operating in the global Breast Cancer Predictive Genetic Testing market include: , Roche, Thermo Fisher Scientific, PerkinElmer, Quest Diagnostics, Myriad Genetics, Iverson Genetics, Cancer Genetics, OncoCyte Corporation, NeoGenomics, Invitae Breast Cancer Predictive Genetic Testing

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1967056/global-breast-cancer-predictive-genetic-testing-market

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Breast Cancer Predictive Genetic Testing market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Global Breast Cancer Predictive Genetic Testing Market Segment By Type:

High Penetrant GenesIntermediate Penetrant GenesLow Penetrant Genes Breast Cancer Predictive Genetic Testing

Global Breast Cancer Predictive Genetic Testing Market Segment By Application:

HospitalsClinicsOther

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Breast Cancer Predictive Genetic Testing market.

Key companies operating in the global Breast Cancer Predictive Genetic Testing market include , Roche, Thermo Fisher Scientific, PerkinElmer, Quest Diagnostics, Myriad Genetics, Iverson Genetics, Cancer Genetics, OncoCyte Corporation, NeoGenomics, Invitae Breast Cancer Predictive Genetic Testing

Key questions answered in the report:

For Discount, Customization in the Report: https://www.qyresearch.com/customize-request/form/1967056/global-breast-cancer-predictive-genetic-testing-market

TOC

1 Report Overview1.1 Study Scope1.2 Key Market Segments1.3 Players Covered: Ranking by Breast Cancer Predictive Genetic Testing Revenue1.4 Market by Type1.4.1 Global Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Type: 2020 VS 20261.4.2 High Penetrant Genes1.4.3 Intermediate Penetrant Genes1.4.4 Low Penetrant Genes1.5 Market by Application1.5.1 Global Breast Cancer Predictive Genetic Testing Market Share by Application: 2020 VS 20261.5.2 Hospitals1.5.3 Clinics1.5.4 Other1.6 Study Objectives1.7 Years Considered 2 Global Growth Trends2.1 Global Breast Cancer Predictive Genetic Testing Market Perspective (2015-2026)2.2 Global Breast Cancer Predictive Genetic Testing Growth Trends by Regions2.2.1 Breast Cancer Predictive Genetic Testing Market Size by Regions: 2015 VS 2020 VS 20262.2.2 Breast Cancer Predictive Genetic Testing Historic Market Share by Regions (2015-2020)2.2.3 Breast Cancer Predictive Genetic Testing Forecasted Market Size by Regions (2021-2026)2.3 Industry Trends and Growth Strategy2.3.1 Market Top Trends2.3.2 Market Drivers2.3.3 Market Challenges2.3.4 Porters Five Forces Analysis2.3.5 Breast Cancer Predictive Genetic Testing Market Growth Strategy2.3.6 Primary Interviews with Key Breast Cancer Predictive Genetic Testing Players (Opinion Leaders) 3 Competition Landscape by Key Players3.1 Global Top Breast Cancer Predictive Genetic Testing Players by Market Size3.1.1 Global Top Breast Cancer Predictive Genetic Testing Players by Revenue (2015-2020)3.1.2 Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Players (2015-2020)3.1.3 Global Breast Cancer Predictive Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.2 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio3.2.1 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio (CR5 and HHI)3.2.2 Global Top 10 and Top 5 Companies by Breast Cancer Predictive Genetic Testing Revenue in 20193.3 Breast Cancer Predictive Genetic Testing Key Players Head office and Area Served3.4 Key Players Breast Cancer Predictive Genetic Testing Product Solution and Service3.5 Date of Enter into Breast Cancer Predictive Genetic Testing Market3.6 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026)4.1 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Type (2015-2020)4.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Type (2021-2026) 5 Market Size by Application (2015-2026)5.1 Global Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020)5.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Application (2021-2026) 6 North America6.1 North America Breast Cancer Predictive Genetic Testing Market Size (2015-2020)6.2 Breast Cancer Predictive Genetic Testing Key Players in North America (2019-2020)6.3 North America Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)6.4 North America Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) 7 Europe7.1 Europe Breast Cancer Predictive Genetic Testing Market Size (2015-2020)7.2 Breast Cancer Predictive Genetic Testing Key Players in Europe (2019-2020)7.3 Europe Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)7.4 Europe Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) 8 China8.1 China Breast Cancer Predictive Genetic Testing Market Size (2015-2020)8.2 Breast Cancer Predictive Genetic Testing Key Players in China (2019-2020)8.3 China Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)8.4 China Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) 9 Japan9.1 Japan Breast Cancer Predictive Genetic Testing Market Size (2015-2020)9.2 Breast Cancer Predictive Genetic Testing Key Players in Japan (2019-2020)9.3 Japan Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)9.4 Japan Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) 10 Southeast Asia10.1 Southeast Asia Breast Cancer Predictive Genetic Testing Market Size (2015-2020)10.2 Breast Cancer Predictive Genetic Testing Key Players in Southeast Asia (2019-2020)10.3 Southeast Asia Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)10.4 Southeast Asia Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) 11 India11.1 India Breast Cancer Predictive Genetic Testing Market Size (2015-2020)11.2 Breast Cancer Predictive Genetic Testing Key Players in India (2019-2020)11.3 India Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)11.4 India Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) 12 Central & South America12.1 Central & South America Breast Cancer Predictive Genetic Testing Market Size (2015-2020)12.2 Breast Cancer Predictive Genetic Testing Key Players in Central & South America (2019-2020)12.3 Central & South America Breast Cancer Predictive Genetic Testing Market Size by Type (2015-2020)12.4 Central & South America Breast Cancer Predictive Genetic Testing Market Size by Application (2015-2020) 13 Key Players Profiles13.1 Roche13.1.1 Roche Company Details13.1.2 Roche Business Overview13.1.3 Roche Breast Cancer Predictive Genetic Testing Introduction13.1.4 Roche Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020))13.1.5 Roche Recent Development13.2 Thermo Fisher Scientific13.2.1 Thermo Fisher Scientific Company Details13.2.2 Thermo Fisher Scientific Business Overview13.2.3 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Introduction13.2.4 Thermo Fisher Scientific Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)13.2.5 Thermo Fisher Scientific Recent Development13.3 PerkinElmer13.3.1 PerkinElmer Company Details13.3.2 PerkinElmer Business Overview13.3.3 PerkinElmer Breast Cancer Predictive Genetic Testing Introduction13.3.4 PerkinElmer Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)13.3.5 PerkinElmer Recent Development13.4 Quest Diagnostics13.4.1 Quest Diagnostics Company Details13.4.2 Quest Diagnostics Business Overview13.4.3 Quest Diagnostics Breast Cancer Predictive Genetic Testing Introduction13.4.4 Quest Diagnostics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)13.4.5 Quest Diagnostics Recent Development13.5 Myriad Genetics13.5.1 Myriad Genetics Company Details13.5.2 Myriad Genetics Business Overview13.5.3 Myriad Genetics Breast Cancer Predictive Genetic Testing Introduction13.5.4 Myriad Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)13.5.5 Myriad Genetics Recent Development13.6 Iverson Genetics13.6.1 Iverson Genetics Company Details13.6.2 Iverson Genetics Business Overview13.6.3 Iverson Genetics Breast Cancer Predictive Genetic Testing Introduction13.6.4 Iverson Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)13.6.5 Iverson Genetics Recent Development13.7 Cancer Genetics13.7.1 Cancer Genetics Company Details13.7.2 Cancer Genetics Business Overview13.7.3 Cancer Genetics Breast Cancer Predictive Genetic Testing Introduction13.7.4 Cancer Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)13.7.5 Cancer Genetics Recent Development13.8 OncoCyte Corporation13.8.1 OncoCyte Corporation Company Details13.8.2 OncoCyte Corporation Business Overview13.8.3 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Introduction13.8.4 OncoCyte Corporation Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)13.8.5 OncoCyte Corporation Recent Development13.9 NeoGenomics13.9.1 NeoGenomics Company Details13.9.2 NeoGenomics Business Overview13.9.3 NeoGenomics Breast Cancer Predictive Genetic Testing Introduction13.9.4 NeoGenomics Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)13.9.5 NeoGenomics Recent Development13.10 Invitae13.10.1 Invitae Company Details13.10.2 Invitae Business Overview13.10.3 Invitae Breast Cancer Predictive Genetic Testing Introduction13.10.4 Invitae Revenue in Breast Cancer Predictive Genetic Testing Business (2015-2020)13.10.5 Invitae Recent Development 14 Analysts Viewpoints/Conclusions 15 Appendix15.1 Research Methodology15.1.1 Methodology/Research Approach15.1.2 Data Source15.2 Disclaimer15.3 Author Details

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

View original post here:
Breast Cancer Predictive Genetic Testing Market 2020-2026: Key Vendor Landscape By Regional Output, Demand By Countries And Future Growth|Roche,...

News Release

Wednesday, August 12, 2020

According to a new study, mortality rates from the most common lung cancer, non-small cell lung cancer (NSCLC), have fallen sharply in the United States in recent years, due primarily to recent advances in treatment.

The study was led by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health. The findings were published August 12, 2020, in the New England Journal of Medicine.

Reduced tobacco consumption in the U.S. has been associated with a progressive decrease in lung cancer deaths that started around 1990 in men and around 2000 in women.Until now, however, we have not known whether newer treatments might contribute to some of the recent improvement, said Douglas R. Lowy, M.D., NCI deputy director and co-author of this study. This analysis shows for the first time that nationwide mortality rates for the most common category of lung cancer, non-small cell lung cancer, are declining faster than its incidence, an advance that correlates with the U.S. Food and Drug Administration approval of several targeted therapies for this cancer in recent years.

In this study, researchers looked at data for both NSCLC, which accounts for 76% of lung cancer in the U.S., and small-cell lung cancer (SCLC), which accounts for 13% (other subtypes of lung cancer that constitute the remaining share of cases were not covered in this study). In the last decade, new treatments for NSCLC have become available, including those that target genetic changes seen in some NSCLC tumors as well as immune checkpoint inhibitors that help the immune system better attack NSCLC. In contrast, there have been limited treatment advancements for SCLC.

Although death records do not distinguish between lung cancer deaths attributable to NSCLC versus SCLC, the cancer diagnosis records compiled by NCIs Surveillance, Epidemiology, and End Results (SEER) cancer registry program do distinguish between these two subtypes of lung cancer. Therefore, the researchers were able to estimate lung cancer mortality trends for these specific lung cancer subtypes by linking the lung cancer death records for each patient back to the incidence data for these patients in the SEER cancer database.

The researchers found that, in recent years, deaths from NSCLC decreased even faster than the decrease in NSCLC incidence and the decrease in deaths was associated with a substantial improvement in survival. Among men, for example, deaths from NSCLC decreased 3.2% annually from 2006 to 2013 and 6.3% annually from 2013 to 2016, whereas incidence decreased 1.9% annually during 2001 to 2008 and 3.1% annually from 2008 to 2016.

Two-year survival for men with NSCLC improved over this time, from 26% for patients diagnosed in 2001 to 35% for those diagnosed in 2014. Similar improvement was observed for women. In addition, improvements in two-year survival were seen for all races/ethnicities, despite concerns that the newer cancer treatments, many of which are expensive, might increase disparities.

The researchers had originally considered the possibility that lung cancer screening might help explain the decreases in NSCLC mortality, but their findings suggest that lung cancer screening rates, which remained low and stable, do not explain the mortality declines. Instead, the rapid decline in deaths reflects both declines in incidence (due in large part to reductions in smoking) and improvement in treatment.

In contrast, the decrease in deaths from SCLC corresponded with the decrease in incidence, and two-year survival was largely unchanged. Among men, for example, deaths declined 4.3% annually and incidence 3.6% annually. Findings were similar among women. The reduced mortality from SCLC over time, therefore, primarily reflects declines in incidence again, due largely to reduced smoking.

The researchers note that the accelerating decline in NSCLC mortality that began in 2013 corresponds with the time when clinicians began routinely testing patients for genetic alterations targeted by newly approved drugs. In 2012, the National Comprehensive Cancer Network recommended that all patients with nonsquamous NSCLC undergo genetic testing. Subsequently, genetic testing for EGFR (epidermal growth factor receptor) mutations and ALK (anaplastic lymphoma kinase) gene rearrangements which are targeted by the newer treatments increased substantially. Because immune checkpoint inhibitors were not in widespread use over the period of the analysis, the authors suspect that most of the survival benefit was attributable to effective EGFR or ALK inhibitors or other advances in therapy. The effect of immune checkpoint inhibitors on NSCLC survival is significant, which suggests that this improving trend in survival should continue beyond 2016.

The survival benefit for patients with non-small cell lung cancer treated with targeted therapies has been demonstrated in clinical trials, but this study highlights the impact of these treatments at the population level, said Nadia Howlader, Ph.D., of NCIs Division of Cancer Control and Population Sciences, who led the study. We can now see the impact of advances in lung cancer treatment on survival.

About the National Cancer Institute (NCI): NCI leads the National Cancer Program and NIHs efforts to dramatically reduce the prevalence of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researchers. For more information about cancer, please visit the NCI website at cancer.gov or call NCIs contact center, the Cancer Information Service, at 1-800-4-CANCER (1-800-422-6237).

About the National Institutes of Health (NIH):NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIHTurning Discovery Into Health

###

Read this article:
New treatments spur sharp reduction in lung cancer mortality rate - National Institutes of Health

A DNA test can augment or jumpstart your understanding of your family history -- from identifying close cousins all the way back to your earliest ancestors. Some tests claim to reveal your "ethnicity" -- though that's a controversial and thorny topic. And some services can shed light on your genetic predisposition for diseases and physiological traits ranging from eye color to your tolerance for cilantro.

Over the past 20 years, DNA testing has entered the mainstream, driven by higher visibility, lower prices and improving science. Back in the aughts, a do-it-yourself DNA test cost about $1,000. But in recent years, the kits have become very affordable, with a wide range of DNA testing companies -- from trailblazers such as 23andMe and Ancestry to upstarts such as Living DNA -- offering rather sophisticated analysis of your genetic makeup for as little as $75 -- or less, if you can find a deal on Black Friday or during the periodic holiday discounts throughout the year.

Now playing: Watch this: Here's how genetic genealogist CeCe Moore finds potential...

7:40

There are three types of DNA tests -- each with its own particular strengths, limitations and rationales.

Once you've been tested, each company will present you with an analysis of your geographical origin; some claim to be able to pinpoint a specific country, town or even "tribe." Some will also serve up "matches" from their DNA databases, which will give you a head start on connecting with possible relatives, and offer some degree of family tree research support. AncestryDNA, for example, offers a subscription service that includes access to hundreds of databases containing birth, death and marriage announcements, census documents, newspaper archives and other historical records.

Some companies sell tests designed for specific ethnicities or specialized kits that claim to shed light on your optimal skin care regimen or weight; others offer tests designed to identify the genetic makeup of your cat or dog. The experts I spoke to were dubious of the efficacy and value of these tests and recommended avoiding them.

If you subscribe to only one CNET newsletter, this is it. Get editors' top picks of the day's most interesting reviews, news stories and videos.

Though there's no blood involved with modern DNA testing -- you either swab the inside of your cheek or fill a small test tube with your saliva -- there are plenty of reasons to be leery of the companies that sell these kits. Your success in DNA test genealogy is largely dependent on supplying highly personal information about yourself and your relatives -- from your genetic data to your mother's maiden name, that traditional cornerstone of password security.

Concerns over data privacy and security are well-founded, and experts warn that regulation -- especially in the US -- lags far behind the technology. And you should know that some DNA testing companies may share data with pharmaceutical companies and law enforcement agencies. Bottom line: Think critically before volunteering information about your health history and familial connections to any DNA testing company or organization.

Read more: In the future, not even your DNA will be sacred

DNA testing, and genealogy more broadly, involves a complicated mixture of genetics, probabilities and guesswork. The various DNA testing services use different labs, algorithms, equipment and criteria to analyze your genetic material; though you should expect some degree of overlap between analyses from different companies, they may differ significantly. There's also an element of critical mass -- the larger the company's database, the larger the sample they use to analyze your results, and the more accurate your test result should be.

We tried some of the top DNA testing services, assessing the breadth and depth of their offerings, methodologies, reputation and price. Take a look at our recommendations below. And if you've taken any of these DNA tests, tell me about your experience with it in the comments below.

Looking for more in-depth info on DNA testing services in general? Jump to our DNA test kit explainer.

Founded in 2006, 23andMe is one of the pioneers of DNA testing for consumers. In 2017 it became the first such service to win the FDA's approval as a risk screener for diseases. It has become one of the most well-known DNA testing companies -- and well-funded, since taking in a $300 million stake from GlaxoSmithKline, which uses the company's customer data to research and design new drugs. Still, the company recently announced a round of layoffs, citing a slowdown in the DNA testing market likely caused by increasing concerns about privacy.

23andMe segments its analysis into three main categories -- health, ancestry and traits. The basic ancestry and traits test, which costs $99, includes an analysis of your genetic makeup including your regions of origin, maternal and paternal lineage and Neanderthal ancestry. Once you opt in, the company's match database -- which has more than 10 million profiles -- will identify and offer to connect you with people who share a DNA match with you.

The company's DNA health test, which starts at $199, adds information about your genetic predisposition for late-onset Alzheimer's, Parkinson's and other diseases. The service also includes analysis of your carrier status as a potential genetic carrier for disorders like Cystic Fibrosis and Sickle Cell Anemia as well as indicators for lactose intolerance and other "wellness" issues. The $499 VIP Health and Ancestry package provides priority lab processing, premium customer support and a personalized walkthrough of your results.

I found 23andMe's website and mobile app very easy to navigate and brimming with interesting, comprehensible information about both my ancestry and health as well as the science of genetics and genealogy. The main dashboard offers intuitive links to exploring your ancestry, learning about the genetic risks for health conditions, building out a family tree and connecting with relatives. Among all of the DNA tests I tried, 23andMe delivered the best introduction to my recent and ancient genealogy along with analysis of my genetic health. The only real drawback is that it does not offer integrated access to historical documents.

23andMe does provide easy access to a full range of privacy preferences and consent options, however. (That noted, 23andMe's terms of service and privacy statement is among the most extensive, exceeding 20,000 words.) You can ask the company to store your saliva sample indefinitely for future testing or have them discard it. Having signed off when I first signed up, I subsequently changed my mind about giving the company permission to share my data with researchers outside of 23andMe, and was able to retract my consent with the click of a button.

Read more:Ancestry vs. 23andMe: Which DNA testing kit is best for tracing your family history?

Founded in Utah in the 1990s, Ancestry.com -- the parent company of AncestryDNA -- started out as a publishing and genealogy company. Since then, it has had a somewhat tumultuous corporate existence, having been bought, sold, publicly traded and then purchased by private equity groups.

The company's basic DNA kit service, which costs $99, provides you with an "ethnicity estimate" derived from its proprietary sequencing techniques. It's noteworthy that the company's genetic testing, which is outsourced to Quest Diagnostics, is distinct from most other companies that use paternal Y chromosome and/or maternal mitochondrial DNA methodologies, and less is known about the particular criteria it uses.

That noted, AncestryDNA's database of 16 million profiles is the largest of all of the testing services. The company also maintains a powerful tool for searching through hundreds of historical document databases -- but any substantive research will quickly bring you to a paywall. Ancestry's databases are further bolstered by its partnership with FamilySearch.org, a genealogical records site run by the Mormon church.

An entry-level membership, which provides access to more than 15 billion US records, costs $99 for six months or $25 per month, after a free two week trial. The "World Explorer" membership, for $40 per month, broadens your access to international records, and the "All Access" tier, starting at $50 per month, includes unlimited access to Ancestry's historical and contemporary database of more than 15,000 newspapers and military records from around the world.

AncestryDNA offers a personalized health report with "actionable insights," access to genetic counseling resources and an online tool to help you map your family's health over generations. But its results are not diagnostic -- though the test result must be approved by one of the company's physicians -- and they do not have FDA approval. For now, 23andMe maintains the advantage when it comes to introductory DNA testing for health risks and genetic screening. But AncestryDNA's service is particularly well-suited for leveraging an introductory DNA analysis into deep historical research to build out a family tree.

AncestryDNA allows you to download your full DNA results profile and upload the raw data into other tools, and it provides reasonably good control over your privacy preferences, though the options are not as granular as others.

Read more: What AncestryDNA taught me about DNA, privacy and the complex world of genetic testing

Founded in 2000, FamilyTreeDNA offers a comprehensive suite of reports and interactive tools to analyze your DNA and build a family tree. With a credible claim to "the world's most comprehensive DNA matching database," FamilyTreeDNA offers all three types of tests -- autosomal DNA, Y-DNA and mtDNA. And it's the sole company to own and operate its own testing facility: The Gene-by-Gene genetic lab, located in Houston.

The company's entry-level "family ancestry" package costs $79 -- though it's frequently discounted to $59. The test results provide information about your ethnic and geographic origins, identifies potential relatives and offers access to the company's massive DNA database. I paid $275 for a broad DNA test that included analysis of my mtDNA and Y-DNA -- tests that cost $119 and $159, respectively, when you buy them individually -- as well as the "Family Finder," the company's autosomal test.

Though the user interface is a bit more complicated than what you'll find on other sites, FamilyTreeDNA provides the most complete suite of introductory tools of any provider I tested. For each type of test, you are presented with matches -- I got more than 22,000 for my autosomal DNA test -- a chromosome browser, migration maps, haplogroups and connections to ancestral reference populations, information about mutations and a link that allows you to download your raw data. Suffice to say, there are numerous threads to pull on to learn about yourself, your family and your health.

FamilyTree also offers a number of higher-end tests, for those interested in digging deeper, including a range of Y-DNA tests that will trace the path of your male ancestors and the history of your surname. The company also allows you to upload raw DNA data files from other services and transfer your autosomal information to its database to expand your universe of matches and relationships.

From a data security and privacy perspective, there are several things I find appealing about FamilyTreeDNA. The company does its own DNA testing in house, processing and storing your sample in its lab. Posted prominently on the front page of its website is a promise that the company will never sell your DNA to third parties. Like most other companies, however, FamilyTreeDNA may use your aggregate genetic information for internal research and may comply with requests from law enforcement -- unless you opt out.

The three services above are our top choices for the best DNA test. But they weren't the only ones we tested. What follows are some additional options, none of which eclipsed the 23andMe, Ancestry or FamilyTreeDNA in any significant fashion.

Based in Israel, MyHeritage was founded in 2003, and like a number of other services profiled here, started out as a genealogy software platform. Over time, it acquired a number of historical databases and eventually added DNA testing in 2016. (MyHeritage outsources its DNA analysis to FamilyTreeDNA.) In 2018, MyHeritage experienced a security breach, exposing the email addresses and hashed passwords of more than 92 million users.

MyHeritage offers a free tier of service that includes some basic family tree-building and access to excerpts of historical documents. It won't get you too far.

The basic DNA testing and analysis service, which starts at $79, includes the usual fare -- a report of your genetic makeup across the company's 42 supported ethnicities, the identification of relatives and connections to them where possible. All things considered, I preferred FamilyTreeDNA's presentation of my DNA information. But MyHeritage highlighted a first cousin living in the US, with whom I shared about 15% of my DNA, and offered to show me her family tree -- if I paid a $209 annual subscription fee.

Yes, that's expensive -- a free 14-day trial is available -- but the company maintains an impressive online database of historical documents that includes 3.5 billion profiles in addition to information about over 100 million subscribers and their collective 46 million family trees. This enormous database is powered by Geni.com, a genealogy social media site that's also MyHeritage's parent company.According to the New York Times, Geni.com has assembled "the world's largest, scientifically vetted family tree."

In 2019, MyHeritage launched a health screening test similar to the one offered by 23andMe. As part of this effort, the company partnered with PWNHealth, a network of US physicians who oversee the process. I was required to complete a personal and family health history questionnaire -- it was 16 questions -- which was then ostensibly reviewed by a doctor. Though the company says it may recommend a "genetic counseling" session administered by PWNHealth, my health results were simply delivered along with my ancestry analysis.

On the plus side, I like MyHeritage's straightforward access to a range of comprehensible privacy preferences. Still, overall, I found MyHeritage's user interface far less intuitive and more difficult to navigate than others. Though the company's offering is broad -- it's one of the few to offer a comprehensive research database of historical documents, DNA analysis and health screening -- I found the integration among them to be a bit clumsy.

Living DNA describes itself as a "consumer genealogy DNA service that does not sell or share customers' DNA or data with third parties," which gives you a sense of its priorities -- or, at least, its sense of customers' concerns. LivingDNA's headquarters in the UK may also be a factor in its distinctive mission statement, as it's subject to the more stringent data and privacy regulations of the GDPR.

LivingDNA divides its offerings in a different way than others. A $49 starter kit provides a "taster" with an introductory overview of your ancestry in eight geographical regions and access to the company's genetic matching tool, in addition to some data about personal fitness and nutrition. The full autosomal DNA testing kit costs $99 and expands the percentage-based ancestry breakdown to 80 regions and features information about maternal and paternal haplogroups. The "wellbeing package" includes reports about your physiological compatibility with vitamins, foods and exercise. And the $149 deluxe package incorporates all of this.

Recent ancestry results are presented with a breakdown of percentage by country as well as the percentage attributable to more detailed regions, as well as the origin and migration path of haplogroups. In February 2020, LivingDNA introduced an African Ancestry DNA test report that features data on 72 regions in Africa and, according to the company, "five times the detail of any other test on the market." The report is available for free to existing customers.

That noted, the company has a very limited family match database; a company representative declined to give me a specific number but said that it contained less than 1 million profiles. My wife, who took the test, returned exactly zero matches. So, if you're looking to identify and make connections with relatives, there are better choices in the market. That noted, LivingDNA has a very solid reputation for both the quality of its DNA analysis and privacy terms among experienced genealogists.

There are a number of companies -- including Full Genomes, Veritas Genetics, Nebula Genomics and Dante Labs -- that can sequence all of your DNA, otherwise known as your genome. This level of analysis is appropriate for advanced users only. Not only is it expensive -- these tests can run into the thousands of dollars, in some cases -- it requires a sophisticated understanding of both genetics and a range of technical tools required to explore and interpret your results.

The least expensive whole genome tests cost about $300. For example, Full Genome's 30X test -- which scans every targeted location of your genome 30 times on average -- is considered the standard for a clinical analysis. It costs $1,800.

For most people, the main rationale for sequencing the whole genome is to dive deep into your genetic health outlook. You can glean your personal risk factors for diseases, drug sensitivities and your status as a carrier; that is, what you might pass on to your kids. But there are also plenty of applications for advanced genealogical projects.

All of these efforts can also be undertaken -- to a less intense degree -- with some of the more affordable options outlined above. But whole genome sequencing provides a significantly more comprehensive, accurate and high resolution analysis.

If you want to dip your toe into this realm. you might want to start with Nebula Genomics. You can also upload an existing DNA sequence from Ancestry or 23andMe's DNA database and get Nebula's reports at a reduced price.

HomeDNA sells testing kits under a number of brands, including DNA Origins, and has a retail presence at Walmart, CVS, Rite Aid and Walgreens. The company's tests claim to combine genetic research and "ancestral tracking" techniques that can identify the town or village where your ancestors originated with a high degree of accuracy. Many experts dispute these claims.

The company offers a range of ancestry testing services starting at $69. That's the price point for the maternal and paternal lineage kits and the "Starter Ancestry Test," which uses DNA markers to develop an estimate of your origins in Europe, Indigenous America, East Asia and Sub-Saharan Africa -- and shows you the modern population groups that share your DNA. The $124 "Advanced Ancestry Test" expands the analysis to 80,000 autosomal genetic markets, 1,000 reference populations and 41 gene pools.

I'll note that the HomeDNA test kit contained no warning about not eating or drinking for any period of time prior to taking the test -- unlike every other kit I used. And of the four swabs the company sent, one broke. The test kit just didn't seem as rigorously hygienic as the others.

For $199, HomeDNA claims that the Asian Edition of its GPS Origins Ancestry Test can analyze 17 Asia-specific gene pools and hundreds of Asia-specific reference populations. In addition to a $164 paternity kit, the company also sells a variety of specific kits to determine your sensitivities to particular animals and foods, one to help you achieve a healthy weight, and another that promises to "unlock your skin's full potential."

For $39, the company will allow you to upload a raw data file from another DNA testing service and pinpoint your origin to a particular town or city. There are also kits to help you identify you screen your dog or cat for genetic diseases and traits.

But this company doesn't have a sterling reputation in the genetic genealogy world. When we recently spoke with Debbie Kennett, a genetic genealogist from University College London, she referenced the company's notoriety for delivering "bizarre results" and expressed doubt about the efficacy of its specialized tests for particular ethnic groups. HomeDNA did not respond to CNET's inquiry about its testing process or results.

And the HomeDNA reports don't stack up particularly well against those returned by other companies. Results are summarized on a single webpage, though you also get a PDF that certifies that you've "undergone DNA testing" and shows the continents and countries where your DNA originates. The company also throws in a boilerplate 20-page explainer about DNA science and technology. HomeDNA does not offer access to any matching databases -- so there's no obvious next step or any actionable data that comes with your results. Given this, I'd recommend choosing a different DNA testing service.

Claiming to have the most comprehensive database of African lineages, African Ancestry promises to trace its customers' ancestry back to a specific country and identify their "ethnic group origin." But a number of experienced genealogists have cited issues with this company's marketing claims and science.

Unlike most other companies, African Ancestry doesn't offer an autosomal DNA test. Instead, it offers an mtDNA test or a Y-DNA test (for males only). In contrast to your standard DNA analysis, African Ancestry's report doesn't provide the percentage of DNA that's likely to have originated across a range of regions. Instead, African Ancestry claims to trace your DNA to a specific region of Africa.

According to experts, however, African Ancestry's DNA tests come up short. As explained in a blog post by African American genetic genealogist Shannon Christmas, the company's methodology simply doesn't analyze a sufficient number of DNA markers to deliver on its marketing promises.

Furthermore, he writes, "Ethnicity is a complex concept, a concept not as rooted in genetics as it is in sociopolitical and cultural constructs. There is no DNA test that can assign anyone to an African ethnic group or what some refer to as an 'African tribe.'" African Ancestry isn't the only company that claims to be able to determine your ethnicity or "ethnic group of origin." But its claim to narrow things down to a single "tribe" of origin is overblown, as any African tribe would ostensibly contain multiple haplogroups.

In an email to CNET, African Ancestry responded: "African Ancestry makes it clear that ethnic groups are social and cultural groupings, not genetic ones. However, based on extensive genetic research of African lineages performed by African Ancestry's co-founder and Scientific Director (who holds a Ph.D. in Biology and specializes in human genetics), we find that contrary to laymen's beliefs, there are ethnic groups that share genetic lineages. Our results pinpoint genetic lineages that share the same genetics as our test takers. Given the vast number of lineages in our African Lineage Database, we are able to provide the ethnic groups of the people with that shared lineage."

The company's PatriClan Test analyzes eight Y-chromosome STRs and the YAP, which it says is a critical identifier for African lineages; and the MatriClan Test analyzes three regions of the mitochondrial DNA: HVS1, HVS2 and HVS3. But though these tests offer lower-resolution results than others, African Ancestry's services are considerably more expensive. The company's Y-DNA test and mtDNA tests cost $299 each -- or you can take them both, and get an eight-pack of "certificates of ancestry" and a four-pack of t-shirts, for $679.

On the plus side, African Ancestry says that it does not maintain a database of customer information and that it will not share or sell your DNA sequence or markers with any third party -- including law enforcement agencies. The company's terms and conditions run to just over 2,200 words, making them considerably more concise than the disclosure statements of most other companies we included in this roundup. And African Ancestry promises to destroy your DNA sample after your test results are delivered.

That said, even if you accept the company's take on tribal and ethnic genetic markers, African Ancestry remains too expensive to recommend at its current price.

If you're using a home DNA testing service, you're likely looking for one of three things:

Ancestry and family history: The first big draw of a full DNA test is that you'll get a detailed breakdown on ancestry and ethnicity, and the migration patterns of your common ancestors. Spoiler alert: Your ethnic background may be radically different than you think it is. You'll also find out what a haplogroup is.

Relative identification: With your permission, some DNA services will let you connect with relatives you never knew you had -- other folks with matching DNA who have used the service and likewise given their permission to connect to possible relations.

Health and disease info: DNA testing can also indicate which conditions for which you may have a preponderance. It's a controversial feature, to be sure. Knowing that you have a genetic predisposition to a certain form of cancer may make you more vigilant for testing, but it may also lead to increased stress -- worrying about a potential health condition that may never develop, even if you're "genetically susceptible" to it. The possibility of false positives and false negatives abound -- any such information should be discussed with your doctor before you act upon it.

Afraid of needles and drawing blood? Good news: That's not an issue with these tests. All you need to do is spit into a vial or rub a swab in your mouth -- all the genetic data needed for these tests is present in your saliva -- and ship the DNA sample to the company for analysis.

The reason that a saliva sample works as well as blood (or hair follicles or skin samples) is that your DNA -- which is short for deoxyribonucleic acid -- is present in all of them. It's the basic genetic code present in all of your cells that makes up your key attributes, from the color of your eyes to the shape of your ears to how susceptible you are to cholesterol.

The key terms you need to know when comparing DNA testing services are:

SNP (single nucleotide polymorphism): Genotyping is done by measuring genetic variation. One of the more common is SNP genotyping, which measures the variations of a single nucleotide polymorphism. The more of these a company measures, the more granular the analysis.

Autosomal DNA testing: An autosomal test that's effective for men and women, and which traces lineage back through both maternal and paternal bloodlines.

Y-DNA: The Y-DNA test can only be administered to men, and traces DNA back through the patrilineal ancestry -- basically from father to grandfather to great grandfather and so on.

mtDNA: The mtDNA is matrilineal and lets you trace your ancestry back through your mother, grandmother, great grandmother and so on.

David Gewirtz contributed to this story. The current version is a major update of past revisions, and includes hands-on impressions of most of the services listed.

The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.

Read more:
Best DNA test in 2020: 23andMe vs. AncestryDNA and more - CNET

New Jersey, United States,- The most recent Direct-to-consumer Genetic Testing Market Research study includes some significant activities of the current market size for the worldwide Direct-to-consumer Genetic Testing market. It presents a point by point analysis dependent on the exhaustive research of the market elements like market size, development situation, potential opportunities, and operation landscape and trend analysis. This report centers around the Direct-to-consumer Genetic Testing business status, presents volume and worth, key market, product type, consumers, regions, and key players.

The COVID-19 pandemic has disrupted lives and is challenging the business landscape globally. Pre and Post COVID-19 market outlook is covered in this report. This is the most recent report, covering the current economic situation after the COVID-19 outbreak.

Key highlights from COVID-19 impact analysis:

Unveiling a brief about the Direct-to-consumer Genetic Testing market competitive scope:

The report includes pivotal details about the manufactured products, and in-depth company profile, remuneration, and other production patterns.

The research study encompasses information pertaining to the market share that every company holds, in tandem with the price pattern graph and the gross margins.

Direct-to-consumer Genetic Testing Market, By Type

Direct-to-consumer Genetic Testing Market, By Application

Other important inclusions in the Direct-to-consumer Genetic Testing market report:

A brief overview of the regional landscape:

Reasons To Buy:

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Fiberglass Mold Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Food Colors Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Gelcoat Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Hydraulic Fluid Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Ion Exchange Resin Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Link:
Direct-to-consumer Genetic Testing Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and Forecast...

Note: Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Direct-to-consumer Genetic TestingMarket which would mention How the Covid-19 is Affecting the Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Key Regions and Proposal for Direct-to-consumer Genetic Testing Market Players to battle Covid-19 Impact.

The Direct-to-consumer Genetic TestingMarket report is compilation of intelligent, broad research studies that will help players and stakeholders to make informed business decisions in future. It offers detailed research and analysis of key aspects of the Direct-to-consumer Genetic Testing market. Readers will be able to gain deeper understanding of the competitive landscape and its future scenarios, crucial dynamics, and leading segments of the global Direct-to-consumer Genetic Testing market. Buyers of the report will have access to accurate PESTLE, SWOT and other types of analysis on the global Direct-to-consumer Genetic Testing market. Moreover, it offers highly accurate estimations on the CAGR, market share, and market size of key regions and countries. Players can use this study to explore untapped Direct-to-consumer Genetic Testing markets to extend their reach and create sales opportunities.

The study encompasses profiles of major Companies/Manufacturers operating in the global Direct-to-consumer Genetic Testing Market.Key players profiled in the report include:23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes and More

Get PDF Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, List of Tables & Figures, Chart):https://www.marketinforeports.com/Market-Reports/Request-Sample/145059

Segmental Analysis:The report has classified the global Direct-to-consumer Genetic Testing market into segments including product type and application. Every segment is evaluated based on share and growth rate. Besides, the analysts have studied the potential regions that may prove rewarding for the Direct-to-consumer Genetic Testing manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, there by helping market players to gain deep insights into the overall Direct-to-consumer Genetic Testing industry.

Key Types:Diagnostic ScreeningPrenatal, Newborn Screening, and Pre-Implantation DiagnosisRelationship Testing

Key End-Use:OnlineOffline

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketinforeports.com/Market-Reports/Request_discount/145059

The authors of the report have analyzed both developing and developed regions considered for the research and analysis of the global Direct-to-consumer Genetic Testing market. The regional analysis section of the report provides an extensive research study on different regional and country-wise Direct-to-consumer Genetic Testing industry to help players plan effective expansion strategies.

Regions Covered in the Global Direct-to-consumer Genetic Testing Market: The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Years Considered to Estimate the Market Size:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year: 2020-2025

For More Information:https://www.marketinforeports.com/Market-Reports/145059/Direct-to-consumer-Genetic-Testing-market

Customization of the Report:Market Info Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Get Customization of the [emailprotected]:https://www.marketinforeports.com/Market-Reports/Request-Customization/145059/Direct-to-consumer-Genetic-Testing-market

Get in Touch with Us :Mr. Marcus KelCall: +1 915 229 3004 (U.S)+44 7452 242832 (U.K)Email: [emailprotected]Website: http://www.marketinforeports.com

Read more here:
Impact of COVID-19 on Global Direct-to-consumer Genetic Testing Market with Covid-19 Effect Analysis | likewise Industry is Booming Globaly with Key...

Michigan scientists have spent years monitoring beach safety by testing the water for pathogens. But now, amid a global pandemic, some researchers are using those same techniques to tack rates of COVID-19 infection. And instead of wading into lake waters, theyre sifting through human waste to find the novel coronavirus.

Thankfully I have two, wonderful, 20-year-old male students who have no problem working with it, said Tami Sivy, chemistry professor at Saginaw Valley.

Sivy and her team of two students have been testing wastewater collected from various waste treatment facilities in the area since April. Its an effort they believe will allow communities to know theyre experiencing a coronavirus surge days before human test results.

But for Sivy and other researchers, the work started at the beach.

For the last five years, the state Department of Environment, Great Lakes and Energy (EGLE) has been working with labs across the state to train them in quantitative polymerase chain reaction, or qPCR methods to provide beach monitoring, said Shannon Briggs, toxicologist in the Water Resources Division of EGLE.

Its a genetic testing method that turns around faster results than previous methods used to test for E. coli on beaches.

And we thought, Why would we want to know tomorrow if we should have swam today? Briggs said.

If a human has been infected with coronavirus, traces of the virus show up in their feces. Scientists are then able to collect samples from wastewater plants and test it for the presence of the virus by looking for the specific sequences in the genetic code that are indicators of the virus being present.

When they collect wastewater they arent working with active virus, because while the virus travels through the digestive track, its effectively killed and researchers dont need the virus to be active to detect it in waste.

Were used to thinking of DNA as genomic material, Sivy said. This virus is an RNA virus, so it has a different type of genomic material.

In the wastewater sample, theyre specifically looking for SARS-CoV-2 RNA, which is responsible for the novel coronavirus. That lets them track how much virus in a given community. But the question then became, what should the researchers do with this data?

We cant just release the results to the public because, number one, theyre not going to necessarily understand. And, number two, you dont want to cause any sort of panic, Sivy said.

Saginaw Valley and other labs work with local health departments of the areas they are sampling. If they see something concerning, they call the health department to warn them that the area could be experiencing a surge in cases - sometimes up to five days before human testing shows an increase.

At Michigan State University, researchers are testing wastewater samples once a week. In June they saw a peak in the amount of virus in the wastewater. They later realized that the peak coincided with an outbreak at Harpers bar in downtown East Lansing.

Harpers bar was connected to more than 180 cases of COVID-19. Harpers remains closed pending authorization to reopen from the Ingham County Health Department.

So now were saying, okay, if we could get this result faster, if we could get it to somebody, and somebody like in public health could go in and maybe improve the messaging, look at whats going on, maybe close activities down that are leading to spread of the virus a little faster, said Joan Rose, water microbiology professor at MSU and Homer Nowlin Chair in Water Research.

Rose said they want to be able to help public health departments, because theyre of course overwhelmed.

Right now, Roses lab is streamlining its testing, she said, and improving the communication with the local health department. Theyve been providing reports to the health departments and theyve spoken with people in the state Department of Health and Human Services, she said.

With students returning to campus soon, Rose said, the testing method will be helpful to track any spread of the virus on campus and be used to supplement testing the university says it will require of symptomatic students and students who may have been exposed.

At the end of July, MSU emailed students to notify them that students living at Holmes Hall, a summer residence hall, had tested positive for COVID-19.

This type of testing cant tell researchers exactly how many people are infected, instead it provides a snapshot of how a community is doing compared to previous weeks. But it could be used to monitor specific areas, like nursing homes, Rose said.

So that if the sewage is negative coming out of a nursing home, they dont have to be tested all the time, she said.

And if we start to see the virus show up or start going up, can you do something quickly before you spread it around to this very sensitive population where mortality is quite a concern, Rose said.

Other labs across the state are working toward using qPCR methods to track coronavirus infection rates.

Oakland University is putting together a public-private partnership to test wastewater in the greater Detroit area and beyond.

Its is working with a private company called Aquasight which has, according to its website, developed a full-service program with sample design and logistics, ddPCR testing lab capabilities, data modeling, digital dashboard and heat maps.

Oakland Universitys lab will work with Aquasight to set up a sewage testing facility. Macomb County Public Works and MSU are also involved with the project, with pilot testing being done in Clinton Township.

The Oakland lab has been using qPCR methods since around 2014, said David Szlag, environmental science associate professor at Oakland University. But he said they want to start testing sewage for COVID-19 because its can help provide public health officials and politicians with usable data to help manage things like allocation of personal protection materials and school or industry closings.

We can see a signal in the sewage about a week before you see that increase in clinical cases. Because were testing the whole community, were catching the asymptomatic people, Szlag said.

The turnaround for the sewage tests is about 24 to 36 hours, Szlag said.

Were going to basically be able to test 100,000 people twice a week, he said. And basically see is the amount of virus increasing or decreasing in this community. And that will precede or lead the clinical data.

The Upper Peninsula could also start seeing wastewater monitoring for COVID-19.

Josh Sharp is an associate professor of Biology at Northern Michigan University. This is their first year doing beach monitoring for e-coli, but theyre already looking to utilize the qPCR methods to test for COVID-19.

Sharp said their lab has done some preliminary studies and shipped wastewater samples to Michigan State, but they still need to train students and staff on using the qPCR method in this way. They also need money for equipment and are currently looking for state and federal funding sources, Sharp said.

The use of this type of testing for COVID-19 has been growing.

Labs across the United States and the world are communicating with each other as part of a global effort to learn from each other to improve the testing methods, Rose from MSU said. And she believes that Michigan labs could play a significant role.

Michigan could really lead the way because theres a lot of interest from across the state, Rose said. Im hearing more communities and more utilities saying Oh I wonder if we can monitor here.

MSU is going to start looking at the cases against the wastewater results from back in April to compare how many cases they were finding in a community with human testing versus how much was found in the sewage, Rose said.

She said Michigan is primed to take a statewide approach, To really watch whats going on, implement prudently, control measures and remind the public and all of us that we can move forward with this and control, hopefully, the spread of the virus.

COVID-19 PREVENTION TIPS

In addition to washing hands regularly and not touching your face, officials recommend practicing social distancing, assuming anyone may be carrying the virus.

Health officials say you should be staying at least 6 feet away from others and working from home, if possible.

Use disinfecting wipes or disinfecting spray cleaners on frequently-touched surfaces in your home (door handles, faucets, countertops) and carry hand sanitizer with you when you go into places like stores.

Michigan Gov. Gretchen Whitmer has also issued executive orders requiring people to wear face coverings over their mouth and nosewhile in public indoor and crowded outdoor spaces. See an explanation of what that means here.

Additional information is available at Michigan.gov/Coronavirus and CDC.gov/Coronavirus.

For more data on COVID-19 in Michigan, visit https://www.mlive.com/coronavirus/data/.

Read more on MLive:

Whitmer vetoes bill to give healthcare workers legal immunity during a state of emergency

Michigans wealthy counties are increasing their reliance on government assistance at a faster pace

Northern Michigan restaurant listed as coronavirus exposure site

Read this article:
How Michigan scientists are using beach testing tools to find COVID-19 infections - MLive.com

New Jersey, United States,- Market Research Intellect aggregates the latest research on At-home Genetic Testing Market to provide a concise overview of market valuation, industry size, SWOT analysis, revenue approximation, and regional outlook for this business vertical. The report accurately addresses the major opportunities and challenges faced by competitors in this industry and presents the existing competitive landscape and corporate strategies implemented by the At-home Genetic Testing market players.

The At-home Genetic Testing market report gathers together the key trends influencing the growth of the industry with respect to competitive scenarios and regions in which the business has been successful. In addition, the study analyzes the various limitations of the industry and uncovers opportunities to establish a growth process. In addition, the report also includes a comprehensive research on industry changes caused by the COVID-19 pandemic, helping investors and other stakeholders make informed decisions.

Key highlights from COVID-19 impact analysis:

Unveiling a brief about the At-home Genetic Testing market competitive scope:

The report includes pivotal details about the manufactured products, and in-depth company profile, remuneration, and other production patterns.

The research study encompasses information pertaining to the market share that every company holds, in tandem with the price pattern graph and the gross margins.

At-home Genetic Testing Market, By Type

At-home Genetic Testing Market, By Application

Other important inclusions in the At-home Genetic Testing market report:

A brief overview of the regional landscape:

Reasons To Buy:

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Digital Out Of Home Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Iris Recognition Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Offshore AUV and ROV Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Oil & Gas Analytics Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Produced Water Treatment Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Go here to see the original:
At-home Genetic Testing Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and Forecast to 2027 -...

New Jersey, United States,- The most recent Direct-To-Consumer (DTC) Genetic Testing Market Research study includes some significant activities of the current market size for the worldwide Direct-To-Consumer (DTC) Genetic Testing market. It presents a point by point analysis dependent on the exhaustive research of the market elements like market size, development situation, potential opportunities, and operation landscape and trend analysis. This report centers around the Direct-To-Consumer (DTC) Genetic Testing business status, presents volume and worth, key market, product type, consumers, regions, and key players.

The COVID-19 pandemic has disrupted lives and is challenging the business landscape globally. Pre and Post COVID-19 market outlook is covered in this report. This is the most recent report, covering the current economic situation after the COVID-19 outbreak.

Key highlights from COVID-19 impact analysis:

Unveiling a brief about the Direct-To-Consumer (DTC) Genetic Testing market competitive scope:

The report includes pivotal details about the manufactured products, and in-depth company profile, remuneration, and other production patterns.

The research study encompasses information pertaining to the market share that every company holds, in tandem with the price pattern graph and the gross margins.

Direct-To-Consumer (DTC) Genetic Testing Market, By Type

Direct-To-Consumer (DTC) Genetic Testing Market, By Application

Other important inclusions in the Direct-To-Consumer (DTC) Genetic Testing market report:

A brief overview of the regional landscape:

Reasons To Buy:

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Temperature Control Dental Laboratory Ovens Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Tennis Skirt Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Tension Control Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Tetrakis (Hydroxymethyl) Phosphonium Sulfate Reagent Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Texturized Vegetable Protein Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

More:
Direct-To-Consumer (DTC) Genetic Testing Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and...

The research report of Preimplantation Genetic Testing Market study report covers all main geographical regions and sub-regions in the world and focuses on product sales, cost, and Preimplantation Genetic Testing market size and growth opportunities in these regions. The Preimplantation Genetic Testing market industry provides market research data status (2013-2018) categorizes the Preimplantation Genetic Testing market into key dynamics, region, type and application.

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential Preimplantation Genetic Testing market trends, and the challenges that the market is facing. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth.

Get a Sample Copy of the Report at https://www.absolutereports.com/enquiry/request-sample/12899958

The data and the information regarding the Preimplantation Genetic Testing Market report are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

Data and information by manufacturer, by region, by type, by application and etc., and custom research can be added according to specific requirements.

Preimplantation Genetic Testing Market by Top Manufacturers:IlluminInc.A.Thermo Fisher Scientific Inc.Agilent TechnologiesInc..PerkinelmerInc..CoopersurgicalInc.. (A Subsidiary of the Cooper CompaniesInc..)ABBott LaboratoriesNaterInc.A.Rubicon Genomics (A Subsidiary of Takara Bio Usa HoldingsInc..)Oxford Gene TechnologyYikon GenomicsScigeneBeijing Genomics InstituteGood Start GeneticsInc..Invicta GeneticsCombimatrix CorporationGenea LimitedProgenesisBy Product: & ServiceReagents & ConsumablesInstrumentsSoftware & ServicesBy Procedure TypePreimplantation Genetic ScreeningPreimplantation Genetic DiagnosisBy Application: -AneuploidyStructural Chromosomal AbnormalitiesSingle Gene DisordersX-linked DisordersHLA TypingGender IdentificationBy End User: -Maternity Centers & Fertility ClinicsHospitalsDiagnostic Labsand Service ProvidersResearch Laboratories & Academic Institutes

Preimplantation Genetic Testing Market by Regions:

The Preimplantation Genetic Testing Market contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Points Covered in The Report

Inquire or share your questions if any before the purchasing this report https://www.absolutereports.com/enquiry/pre-order-enquiry/12899958

The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report.

The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.

Key Reasons to Purchase

Detailed Global and Regional Preimplantation Genetic Testing Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report Standard Version

Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and

1.4.2 East Asia Market States and

1.4.3 Europe Market States and

1.4.4 South Asia Market States and

1.4.5 Southeast Asia Market States and

1.4.6 Middle East Market States and

1.4.7 Africa Market States and

1.4.8 Oceania Market States and

1.4.9 South America Market States and

1.5 Global Preimplantation Genetic Testing Market Size Analysis

1.5.1 Global Preimplantation Genetic Testing Market Size Analysis by Consumption Volume

1.5.2 Global Preimplantation Genetic Testing Market Size Analysis by Value

1.5.3 Global Preimplantation Genetic Testing Price Trends Analysis

1.6 Preimplantation Genetic Testing Industry Impact

Chapter 2 Global Preimplantation Genetic Testing Competition by Types, Applications, and Top Regions and Countries

2.1 Global Preimplantation Genetic Testing (Volume and Value) by Type

2.1.1 Global Preimplantation Genetic Testing Consumption and Market Share by Type

2.1.2 Global Preimplantation Genetic Testing Revenue and Market Share by Type

2.2 Global Preimplantation Genetic Testing (Volume and Value) by Application

2.2.1 Global Preimplantation Genetic Testing Consumption and Market Share by Application

2.2.2 Global Preimplantation Genetic Testing Revenue and Market Share by Application

2.3 Global Preimplantation Genetic Testing (Volume and Value) by Regions

2.3.1 Global Preimplantation Genetic Testing Consumption and Market Share by Regions

2.3.2 Global Preimplantation Genetic Testing Revenue and Market Share by Regions

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2015-2020 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2015-2020 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2015-2020 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Preimplantation Genetic Testing Sales, Consumption, Export, Import by Regions

4.1 Global Preimplantation Genetic Testing Consumption by Regions

4.2 North America Preimplantation Genetic Testing Sales, Consumption, Export, Import

4.3 East Asia Preimplantation Genetic Testing Sales, Consumption, Export, Import

4.4 Europe Preimplantation Genetic Testing Sales, Consumption, Export, Import

4.5 South Asia Preimplantation Genetic Testing Sales, Consumption, Export, Import

4.6 Southeast Asia Preimplantation Genetic Testing Sales, Consumption, Export, Import

4.7 Middle East Preimplantation Genetic Testing Sales, Consumption, Export, Import

4.8 Africa Preimplantation Genetic Testing Sales, Consumption, Export, Import

4.9 Oceania Preimplantation Genetic Testing Sales, Consumption, Export, Import

4.10 South America Preimplantation Genetic Testing Sales, Consumption, Export, Import

Chapter 5 North America Preimplantation Genetic Testing Market Analysis

5.1 North America Preimplantation Genetic Testing Consumption and Value Analysis

5.1.1 North America Preimplantation Genetic Testing Market

5.2 North America Preimplantation Genetic Testing Consumption Volume by Types

5.3 North America Preimplantation Genetic Testing Consumption Structure by Application

5.4 North America Preimplantation Genetic Testing Consumption by Top Countries

5.4.1 United States Preimplantation Genetic Testing Consumption Volume

5.4.2 Canada Preimplantation Genetic Testing Consumption Volume

5.4.3 Mexico Preimplantation Genetic Testing Consumption Volume

..And many More

Purchase This Report (Price 3500 USD for single user license) https://www.absolutereports.com/purchase/12899958

Our Other report :Global Polymers (HDPE, LLDPE, PP) Market 2020 Production, Revenue, Price and Gross Margin Analysis with Forecasts to 2024

Wood Coatings Resin Market 2020 Structure, Research Methodology Forecast to 2024

Lauryl Hydroxysultaine (LHSB) Market 2020 Overview Industry, Definition, Specifications and Classification and Forecast to 2024

Global Methyl Diethanolamine Market Segmentation and Analysis by Recent Trends, Development Trends and Growth Rate by Regions to 2025

Unmanned Aerial Vehicles (UAV) Market 2019 Overview, Cost Structure Analysis, Growth Opportunities and Forecast to 2024

Global Grapefruit Oil Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Electronic Material Recycling Market 2020 analysis with Key Players, Applications, Trends and Forecasts by 2025

Project Portfolio Management (PPM) Solutons Market Analysis including Size, Share, Key Drivers, Growth Opportunities and Trends 2020 2024

Sport-fishing Super-yachts Market 2020 Global Industry Share, Size, Share, Demand, Key Findings, Regional Analysis, Key Players Profiles, Future Prospects and Forecasts to 2026

Visit link:
Preimplantation Genetic Testing Market Analysis and Prediction by Leading Manufacturers, Its Application and Types with Region by 2023 - Bulletin Line

Associate research specialist Miranda Stauss and senior scientist Roger Wiseman process small vials of spit collected from volunteers.

At far right, Tom Friedrich, professor in the UW School of Veterinary Medicine, explains a consent form as his colleague Matt Reynolds, center, assistant professor in the UW School of Veterinary Medicine, hands a volunteer small vial for collecting spit as part of a trial of a new COVID-19 saliva test.

A volunteer spits in a small vial as part of a trial of a new COVID-19 saliva test.

A vial with saliva is processed as part of a trial of a new COVID-19 saliva test.

Wearing an N95 face masks, associate research specialist Miranda Stauss and senior scientist Roger Wiseman process small vials of spit collected from volunteers as part of a trial.

Researchers sort small vials of spit collected from volunteers.

Stauss processes small vials of spit.

Vials of spit are collected from volunteers as part of the trial.

Volunteers at four sites in Madison are being tested for the virus that causes COVID-19 by spitting in a vial, which may prove faster, cheaper and less complicated than other common tests, according to University of WisconsinMadison researchers.

Scientists from UWMadisons AIDS Vaccine Research Laboratory, a team that in recent years has also turned its attention to COVID-19 and Zika virus outbreaks as need arose, have tuned a relatively simple genetic testing process to find evidence of the novel coronavirus in saliva.

With support from a National Institutes of Health grant program that hopes to expand testing in the United States by fall, the researchers have collected hundreds of samples from volunteers at three UWMadison sites and a local elementary school. The tests were completed in hours, a stark contrast to common wait times of several days or even weeks for results from other kinds of COVID-19 tests.

Tom Friedrich, professor in the UW School of Veterinary Medicine, explains a consent form and the process of volunteers spitting in a small vial as part of a trial of a new COVID-19 saliva test.

This sort of testing, if it is successful and can be expanded, offers hope that schools and workplaces could receive rapid turnaround testing to assist in the complex decision of managing education during the outbreak with a test that is still sensitive enough to catch the people who are contagious, but exceptional in terms of accessibility, cost, and turnaround time says David OConnor, professor at the UW School of Medicine and Public Health.

They made their early findings available in late July in a brief study posted on medRxiv, a website for health sciences research that has not yet been peer-reviewed and published in a scientific journal. The test has not been approved for clinical diagnosis. The UWMadison researchers are studying whether this type of test can be administered frequently and efficiently.

Recent studies show that frequent, repeated testing is key to detecting infected people quickly, says Tom Friedrich, professor in the UW School of Veterinary Medicine. Because people can be contagious before they show symptoms of COVID-19, rapid testing can allow them to isolate and protect others before they even realize they are infected.

The project started in February even before the first COVID-19 cases appeared in Madison when OConnor and Friedrich were working with UW Hospital and Clinics to see if recent flu-like illnesses were actually the new virus.

We were interested in knowing whether there was silent spread of the virus in Madison, says OConnor. Fortunately, diagnostic testing became available very quickly. We shifted gears to adapting an alternative type of nucleic acid testing.

Most testing for SARS-CoV-2, the virus that causes COVID-19, uses a chemical process called polymerase chain reaction, or PCR, to make copies of the genetic material in a small sample so they are easier to identify. The Madison group employs a different method, called reverse-transcriptase loop-mediated isothermal amplification (RT-LAMP) to amplify the identifiable parts of virus available in saliva samples.

The advantage of RT-LAMP is that it is easier to set up than PCR, and doesnt require specialized instrumentation, OConnor says. We realized that this sort of testing might be more appropriate for places like workplaces, schools and nursing homes that might require on-site, frequent, repeated testing.

RT-LAMP also uses different chemicals than the PCR process, which has become so vital to pandemic testing that supply chains and manufacturing capacity have been stretched thin. And RT-LAMP requires fewer steps, using simpler and less expensive instrumentation than PCR.

I set up an (RT-LAMP kit) one Saturday afternoon and confirmed that indeed we could do the assay, says AVRL scientist Dawn Dudley. However, it soon became clear that this technique was not as sensitive as PCR especially in its easiest form.

Both PCR and RT-LAMP processes work better if the genetic material the nucleic acids that make up DNA and RNA are separated from the rest of the stuff in saliva, but the simplest version of RT-LAMP skipped that step. David Beebe, a UWMadison pathology professor with experience in putting lab tests on small, reproducible chips, and Salus, the Madison-based spinoff company he helped create in 2013, joined the group to design and produce an extraction process that would work outside lab settings and make the RT-LAMP test much more accurate with a small saliva sample.

Dudley and scientist Christina Newman spent months adapting the test for saliva, because the group expected people would get pretty tired of the common sampling method, a swab (now also in short supply) run sometimes deep into the nose.

Scientists Roger Wiseman and Miranda Stauss process small vials of spit collected from volunteers.

Collection is more comfortable, which is especially important if you are getting tested twice a week and important for children, Dudley says. Swabs can be quite invasive and somewhat damaging over time. Spitting into a tube? Not so bad.

Newman also set up the testing sites including AVRL and the Wisconsin National Primate Research Center where the researchers unload their gear from a minivan twice a week and collect samples across a folding table from as many as 60 people on some days.

Basically, people come, sign the consent, and spit into a tube that is left in a cooler, Dudley says. It takes less than five minutes.

With small groups, processing can be finished, results read via a color change in the test tube and delivered in a matter of hours and probably without a team of lab-trained scientists.

Other groups are also testing the effectiveness of the new test. Chris Mason, a UWMadison alum who is now a professor at Cornell University, is running a trial of his labs LAMP-based test with city workers in Racine, Wisconsin, where the collecting and processing is done mostly by firefighters. Salus is working on a commercial version of the test that can be deployed in small, mobile labs that Newman says could be straightforward enough to be operated by people without lengthy lab science training.

The researchers have run more than 400 tests, finding two positive cases and one that may be a false positive. Each result positive and negative, save the potential false positive has been confirmed laterby checking the saliva sample with the clinical-lab-standard PCR testing. Because the RT-LAMP test is not yet approved for clinical diagnosis of COVID-19 infection, the researchers have UW Hospital and Clinics doctors contact volunteers who tested positive and advise them to get a PCR test as soon as possible.

Read this article:
Simpler COVID-19 test could provide results in hours from saliva - University of Wisconsin-Madison

Global Genetic testing services Market presents an in-depth review and technical research, with useful facts and figures, of the current and future state of the Genetic testing services market worldwide. Genetic testing services market provides information on emerging market opportunities and business factors, developments and evolving technologies that will fuel these growth trends. The report provides a comprehensive overview including Comparison of Definitions, Range, Use, Production and CAGR (percent), Form Segmentation, Share, Revenue Status and Outlook, Capacity, Demand, Market Drivers, Production Status, and Outlook and Opportunities, Export, Import, Growth Rate for Emerging Markets / Countries.

Get Sample Copy of this Report https://www.factmr.com/connectus/sample?flag=S&rep_id=4744

Our industry professionals are working reluctantly to understand, assemble and timely deliver assessment on impact of COVID-19 disaster on many corporations and their clients to help them in taking excellent business decisions. We acknowledge everyone who is doing their part in this financial and healthcare crisis.

The market research study on Genetic testing services was collected through comprehensive primary research through interviews, surveys, and findings of experienced analysts and secondary research. The study also provides a complete qualitative and quantitative assessment by analyzing data obtained from industry analysts and market participants from Genetic testing services around key points in the value chain of the industry.

The Regional Analysis of This Report Covers the Following Major Companies

Useful findings of this research are-

-Study of historical data.

-Analysis of existing scenarios in every domestic and national sector.

-Study of patterns, accessible knowledge and data figures.

-Use of validated project methods for the next five years.

Statistical analysis, figures and prime data included in the report contains-

-Market size (current and projected for the last few years)

-Market share analysis as per different companies)

-Market forecast)

-Demand)

-Price analysis)

-Market contributions (Size, Share according to geographical boundaries)

The report benefits Market Investigators, companies, Vendors, Buyers, Suppliers, Individual professionals and Competitive organizations

A Customization of this Report is Available upon Request https://www.factmr.com/connectus/sample?flag=RM&rep_id=4744

Genetic testing services Market Segmentations type:

By Product Type:

By End-User:

By Region:

Why Choose Fact.MR?

Fact.MR follows a multi- disciplinary approach to extract information about various industries. Our analysts perform thorough primary and secondary research to gather data associated with the market. With modern industrial and digitalization tools, we provide avant-garde business ideas to our clients. We address clients living in across parts of the world with our 24/7 service availability.

Contact:

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai, United Arab Emirates

MARKET ACCESS DMCC Initiative

Email: sales@factmr.com

Web: https://www.factmr.com/

Read the original:
New Fact.MR Report: Impact of COVID-19 Crisis on Genetic Testing Services Market Production and Demand 2020 2025 - The Cloud Tribune

Editors note: You might have heard that being pregnant, trying to get pregnant, or delivering right about now is strange, in this age of coronavirus. But how? In what ways? Were going to show you -- with a different persons experience each week. To contribute your own story, scroll all the way to the bottom of this article and tap the link.

Going though in vitro fertilization, or IVF, under normal circumstances, can be a challenge, both mentally and physically -- and for some, thats phrasing it mildly.

Youre going in for bloodwork, sometimes every other day. Youre attending never-ending doctors appointments. Theres a ton on your mind and you just want everything to go well. Its an often-heavy process.

Take it from Sarah*, who asked that we not use her real name, for privacy reasons. Sarah is 32, married, and lives in Farmington Hills, Michigan. She didnt mince words when it came to describing her own IVF situation. Some examples:

Ugh. No one wants to hear of another human going through something like that.

So imagine then, that your support person, like in Sarahs case, her husband, is now unable to attend any of those painful procedures or appointments.

Its scary, Sarah said.

Its also unprecedented. Safe to say, no one assumed the globe would be gripped by a pandemic this year; a true health crisis -- and no one knows when things will return to normal.

But dont get her wrong: Sarah is grateful that shes able to proceed with IVF -- which, spoiler alert, she is. (More on that soon!)

She even added that the couple has decent insurance, and said for many, theyre not so lucky. Most insurance companies dont cover things like IVF, which can total as much as $40,000 for just one round.

But all that money talk, that feels stressful, too. Sarah said if she were to contract COVID-19, her cycle would be canceled. Thats a frightening thought, lingering over ones head.

So then youd be out money, time and pain, Sarah said. (Its like), is it worth it to be doing this?

Sarah has been knee-deep in all things IVF-related for much of the year. She began the journey and went through round one starting in February.

First up, she had two to three weeks of injections, to hopefully produce more eggs.

Sarah took the injections, and then doctors performed a surgery to retrieve her eggs. She said she got through it just fine.

Next, this is typically the time when, if you had any embryos that made it through the egg-retrieval process, the doctors will mix them with sperm, and then youd transfer.

For Sarah, this was when COVID-19 arrived in the United States and started becoming more and more of a growing concern.

She and her husband had ended up with one embryo, so the next step would be a second surgery to make sure nothing is blocking the implantation of said embryo.

But COVID hit right when I was scheduled to go in, Sarah said. So we decided to postpone (and) see how things would play out.

That felt frustrating for the couple, too.

Theyve been playing the waiting game for a long time -- married 6 years, and trying for a baby for about four of those years.

And we dont have a lot of time to wait, Sarah said. We dont want the issues (that led us to IVF in the first place) to get any worse, and were not getting any younger.

Sarah and her husband opted to move forward with the second surgery.

And with the coronavirus pandemic continuing, You had to go through it alone, when youre already scared, Sarah said.

Doctors were able to perform the transfer, but Sarahs husband wasnt allowed to attend.

The whole process is devastating, Sarah said. Youre getting ready to conceive a child and your husband cant even be there.

It was already a tense time.

Then, the couple learned that their embryo transfer failed.

You want answers right away, Sarah said. But doctors arent meeting. So you need to wait for a Zoom call. Youre not being able to see your results and youre not being able to get answers.

Having to survive the failed transfer during quarantine was really tough.

Most doctors (tell you) to stay busy and lean on your support system during all (the waiting), Sarah said.

Because indeed, there is a lot of waiting. More than you might imagine.

(When it comes to) waiting for results in IVF, theres waiting a week to find out if you were able to get any embryos after the first round of injections and egg retrieval surgery, Sarah said. (Then you wait) another two weeks after that for genetic testing on those embryos to see if they are viable, and then of course, the two weeks waiting to find out if youre pregnant after the embryo transfer to see if all your efforts worked.

And, considering coronavirus, Sarah said, all of the now-solo waiting felt especially challenging.

Youre just trapped at home and not able to stay busy to keep yourself mentally healthy, she recalled. I know for me, my friends and family have been my rock during these four years leading to IVF. ... Its been so hard, being isolated.

In discussing the future with Sarah, she sounds optimistic: Theres something cheerful in her tone, and shes so willing to open up and chat about all of this with a total stranger (editors note: which I so admire!)

She and her husband will try again. In fact, theyre set to start a second round of IVF in September.

Her husband has been one of her only comforts throughout this strange time, Sarah said, so she hopes she can have him present for more in-person appointments and procedures this time around. But the future remains incredibly uncertain.

We dont know whats going to happen, Sarah said. In an ideal world, Id probably wait. But with time constraints, you have to try.

Sarah and her husband will likely hole up a bit, leading up to their second IVF round. Luckily, they both have jobs that allow them to work from home. Its a seemingly small perk, but it becomes quite notable through all of this.

And then two weeks or so before the cycle, Sarah said, itll start: Theyll be extra cautious and they wont leave the house until its all over. Too much is at stake.

It makes sense.

Sarah said she wants to help show a different perspective when it comes to pregnancy.

After all, shes had just as many doctors appointments and stressors, if not more, than your average expecting mother.

I hope it helps others who are in the same boat, she said.

Here is the original post:
My (hopeful) pandemic pregnancy: Inside the world of IVF and COVID-19 -- Its terrifying' - KSAT San Antonio

Genes and Ovarian Cancer

Diagnosing ovarian cancer can involve a number of tests, including a physical exam, ultrasound, and blood tests. Genetic testing is also an important part of the diagnostic process, helping to not only detect ovarian cancers, but also find the right treatment for them.

About 15% of ovarian cancers are linked to gene changes called mutations that can be passed down through families. The most common genetic cause of ovarian cancer is a mutation in the BRCA1 or BRCA2 gene. These genes help to repair damaged DNA, and ensure the stability of the cells genetic material. If either of these genes is mutated, DNA damage continues to the point where it can eventually cause the cells to turn cancerous.

Most people who carry a BRCA gene mutation dont realize they have it until someone in their family is diagnosed with cancer. This is why its important for any new diagnosis of ovarian cancer to undergo genetic testing, to see if they are, in fact, a carrier, says Dr. Adam ElNaggar, a gynecologic oncologist at West Cancer Center in Memphis, Tennessee.

Certain groups of people, like Ashkenazi Jews or those whose families originated in Mediterranean countries, are especially susceptible to these mutations. Anyone with a family history of breast or ovarian cancer should ask their doctor about getting tested. Carrying one of the BRCA genes puts you at increased risk not only for ovarian cancer, but also for breast cancer and for other, less common cancers, Dr. ElNaggar says. Knowing your status could help you and your family stay on top of screenings for these other cancers, too.

Although guidelines recommend that all women with ovarian cancer have genetic testing when theyre diagnosed, only a small percentageof women actually do get tested, research finds. Regardless of your age or the type of ovarian cancer you have, testing should be part of your diagnosis.Besides providing valuable information to help your doctor decide on the best treatment for your cancer, knowing that you carry a genetic mutation is valuable for other family members, too. Your immediate family may also benefit from genetic testing. If they find they carry a BRCA1 or BRCA2 mutation it may be recommended that they begin undergoing more frequent screening tests for breast and ovarian cancer, and possibly even consider prophylactic surgery to avoid developing advanced cancer.

Gene mutations not only increase the risk of developing ovarian cancer, but they also can make certain types of treatments, like PARP inhibitor drugsmore effective. PARP is an enzyme that cells normally use to repair their damaged DNA. PARP inhibitors block this enzyme to prevent ovarian cancers with BRCA mutations from fixing DNA damage.

Three PARP inhibitors are approved to treat ovarian cancer:

Some women with ovarian cancer have another genetic marker called homologous recombination deficiency (HRD) that makes them particularly good candidates for PARP inhibitors. Ovarian cancers with HRD are already less able to repair their DNA damage, making them easier for the drugs to fight.

If you picture your DNA like a railroad track, there are two beams, as well as the cross lattice of woodwork, Dr. El Naggar says. When a section of that is taken out, your HRD genes would have come in and put that track back together, repairing both tracks. However, when theyre deficient, the body is unable to do that.

When only one track is broken in other words, one strand of DNA PARP enzymes come in and fix the damage so the cancer cell can keep growing. PARP inhibitors block that repair process which prevents the cancer cells from replicating spreading.

Data shows that PARP inhibitors can have the best results in women with a BRCA mutation or HRD, but new studies show that one PARP inhibitor, niraparib (brand name ZEJULA) may provide some benefit for women without these mutations, as well. These drugs can be used initially with chemotherapy and surgery in what is called first-line treatment, or as maintenance therapy to prevent the cancer from returning after treatment.

Genetic testing can benefit you if youve been diagnosed with ovarian cancer, by helping your doctor determine whether a treatment like a PARP inhibitor is likely to be effective against your cancer. It can also inform your family members, enabling them to be more diligent about getting genetic testing and cancer screening.

Learn more about SurvivorNet's rigorous medical review process.

Dr. Adam ElNaggar is an assistant professor of gynecologic oncology at the University of Tennessee Health Science Center (UTHSC), and director of gynecologic cancer research at the West Cancer Center.Hisclinical interests include personalized medicine, advanced surgical techniques, and targeted therapies. Read More

About 15% of ovarian cancers are linked to gene changes called mutations that can be passed down through families. The most common genetic cause of ovarian cancer is a mutation in the BRCA1 or BRCA2 gene. These genes help to repair damaged DNA, and ensure the stability of the cells genetic material. If either of these genes is mutated, DNA damage continues to the point where it can eventually cause the cells to turn cancerous.

Certain groups of people, like Ashkenazi Jews or those whose families originated in Mediterranean countries, are especially susceptible to these mutations. Anyone with a family history of breast or ovarian cancer should ask their doctor about getting tested. Carrying one of the BRCA genes puts you at increased risk not only for ovarian cancer, but also for breast cancer and for other, less common cancers, Dr. ElNaggar says. Knowing your status could help you and your family stay on top of screenings for these other cancers, too.

Although guidelines recommend that all women with ovarian cancer have genetic testing when theyre diagnosed, only a small percentageof women actually do get tested, research finds. Regardless of your age or the type of ovarian cancer you have, testing should be part of your diagnosis.Besides providing valuable information to help your doctor decide on the best treatment for your cancer, knowing that you carry a genetic mutation is valuable for other family members, too. Your immediate family may also benefit from genetic testing. If they find they carry a BRCA1 or BRCA2 mutation it may be recommended that they begin undergoing more frequent screening tests for breast and ovarian cancer, and possibly even consider prophylactic surgery to avoid developing advanced cancer.

Gene mutations not only increase the risk of developing ovarian cancer, but they also can make certain types of treatments, like PARP inhibitor drugsmore effective. PARP is an enzyme that cells normally use to repair their damaged DNA. PARP inhibitors block this enzyme to prevent ovarian cancers with BRCA mutations from fixing DNA damage.

Three PARP inhibitors are approved to treat ovarian cancer:

Some women with ovarian cancer have another genetic marker called homologous recombination deficiency (HRD) that makes them particularly good candidates for PARP inhibitors. Ovarian cancers with HRD are already less able to repair their DNA damage, making them easier for the drugs to fight.

If you picture your DNA like a railroad track, there are two beams, as well as the cross lattice of woodwork, Dr. El Naggar says. When a section of that is taken out, your HRD genes would have come in and put that track back together, repairing both tracks. However, when theyre deficient, the body is unable to do that.

When only one track is broken in other words, one strand of DNA PARP enzymes come in and fix the damage so the cancer cell can keep growing. PARP inhibitors block that repair process which prevents the cancer cells from replicating spreading.

Data shows that PARP inhibitors can have the best results in women with a BRCA mutation or HRD, but new studies show that one PARP inhibitor, niraparib (brand name ZEJULA) may provide some benefit for women without these mutations, as well. These drugs can be used initially with chemotherapy and surgery in what is called first-line treatment, or as maintenance therapy to prevent the cancer from returning after treatment.

Genetic testing can benefit you if youve been diagnosed with ovarian cancer, by helping your doctor determine whether a treatment like a PARP inhibitor is likely to be effective against your cancer. It can also inform your family members, enabling them to be more diligent about getting genetic testing and cancer screening.

Learn more about SurvivorNet's rigorous medical review process.

Dr. Adam ElNaggar is an assistant professor of gynecologic oncology at the University of Tennessee Health Science Center (UTHSC), and director of gynecologic cancer research at the West Cancer Center.Hisclinical interests include personalized medicine, advanced surgical techniques, and targeted therapies. Read More

Originally posted here:
The Important Role of Genetics in Ovarian Cancer Treatment - SurvivorNet

Overview for Breast Cancer Predictive Genetic Testing Market Helps in providing scope and definitions, Key Findings, Growth Drivers, and Various Dynamics.

The Breast Cancer Predictive Genetic Testing market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Breast Cancer Predictive Genetic Testing market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Breast Cancer Predictive Genetic Testing market. The report focuses on well-known providers in the global Breast Cancer Predictive Genetic Testing industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Breast Cancer Predictive Genetic Testing Industry will develop is also analyzed in detail in Chapter 1.7 of the report.In Chapter 2.4, we analyzed industry trends in the context of COVID-19.In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Download PDF Sample of Breast Cancer Predictive Genetic Testing Market report @ https://www.arcognizance.com/enquiry-sample/1196631

Key players in the global Breast Cancer Predictive Genetic Testing market covered in Chapter 4:OncoCyte CorporationMyriad GeneticsThermo Fisher ScientificQuest DiagnosticsCancer GeneticsInvitaePerkinElmerNeoGenomicsRocheIverson Genetics

In Chapter 11 and 13.3, on the basis of types, the Breast Cancer Predictive Genetic Testing market from 2015 to 2026 is primarily split into:High Penetrant GenesIntermediate Penetrant GenesLow Penetrant Genes

In Chapter 12 and 13.4, on the basis of applications, the Breast Cancer Predictive Genetic Testing market from 2015 to 2026 covers:HospitalsClinicsOther

Brief about Breast Cancer Predictive Genetic Testing Market Report with [emailprotected] https://www.arcognizance.com/report/global-breast-cancer-predictive-genetic-testing-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:North America (Covered in Chapter 6 and 13)United StatesCanadaMexicoEurope (Covered in Chapter 7 and 13)GermanyUKFranceItalySpainRussiaOthersAsia-Pacific (Covered in Chapter 8 and 13)ChinaJapanSouth KoreaAustraliaIndiaSoutheast AsiaOthersMiddle East and Africa (Covered in Chapter 9 and 13)Saudi ArabiaUAEEgyptNigeriaSouth AfricaOthersSouth America (Covered in Chapter 10 and 13)BrazilArgentinaColumbiaChileOthers

Years considered for this report:Historical Years: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Period: 2020-2026

Single User License Copy and Other Purchase [emailprotected] https://www.arcognizance.com/purchase/1196631

Some Point of Table of Content:

Chapter One: Report Overview

Chapter Two: Global Market Growth Trends

Chapter Three: Value Chain of Breast Cancer Predictive Genetic Testing Market

Chapter Four: Players Profiles

Chapter Five: Global Breast Cancer Predictive Genetic Testing Market Analysis by Regions

Chapter Six: North America Breast Cancer Predictive Genetic Testing Market Analysis by Countries

Chapter Seven: Europe Breast Cancer Predictive Genetic Testing Market Analysis by Countries

Chapter Eight: Asia-Pacific Breast Cancer Predictive Genetic Testing Market Analysis by Countries

Chapter Nine: Middle East and Africa Breast Cancer Predictive Genetic Testing Market Analysis by Countries

Chapter Ten: South America Breast Cancer Predictive Genetic Testing Market Analysis by Countries

Chapter Eleven: Global Breast Cancer Predictive Genetic Testing Market Segment by Types

Chapter Twelve: Global Breast Cancer Predictive Genetic Testing Market Segment by Applications12.1 Global Breast Cancer Predictive Genetic Testing Sales, Revenue and Market Share by Applications (2015-2020)12.1.1 Global Breast Cancer Predictive Genetic Testing Sales and Market Share by Applications (2015-2020)12.1.2 Global Breast Cancer Predictive Genetic Testing Revenue and Market Share by Applications (2015-2020)12.2 Hospitals Sales, Revenue and Growth Rate (2015-2020)12.3 Clinics Sales, Revenue and Growth Rate (2015-2020)12.4 Other Sales, Revenue and Growth Rate (2015-2020)

Chapter Thirteen: Breast Cancer Predictive Genetic Testing Market Forecast by Regions (2020-2026)continued

To Check Discount of Breast Cancer Predictive Genetic Testing Market @ https://www.arcognizance.com/discount/1196631

List of tablesList of Tables and FiguresTable Global Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Type (2020-2026)Figure Global Breast Cancer Predictive Genetic Testing Market Share by Type in 2019 & 2026Figure High Penetrant Genes FeaturesFigure Intermediate Penetrant Genes FeaturesFigure Low Penetrant Genes FeaturesTable Global Breast Cancer Predictive Genetic Testing Market Size Growth by Application (2020-2026)Figure Global Breast Cancer Predictive Genetic Testing Market Share by Application in 2019 & 2026Figure Hospitals DescriptionFigure Clinics DescriptionFigure Other DescriptionFigure Global COVID-19 Status OverviewTable Influence of COVID-19 Outbreak on Breast Cancer Predictive Genetic Testing Industry DevelopmentTable SWOT AnalysisFigure Porters Five Forces AnalysisFigure Global Breast Cancer Predictive Genetic Testing Market Size and Growth Rate 2015-2026Table Industry NewsTable Industry PoliciesFigure Value Chain Status of Breast Cancer Predictive Genetic TestingFigure Production Process of Breast Cancer Predictive Genetic TestingFigure Manufacturing Cost Structure of Breast Cancer Predictive Genetic TestingFigure Major Company Analysis (by Business Distribution Base, by Product Type)Table Downstream Major Customer Analysis (by Region)Table OncoCyte Corporation ProfileTable OncoCyte Corporation Production, Value, Price, Gross Margin 2015-2020Table Myriad Genetics ProfileTable Myriad Genetics Production, Value, Price, Gross Margin 2015-2020Table Thermo Fisher Scientific ProfileTable Thermo Fisher Scientific Production, Value, Price, Gross Margin 2015-2020Table Quest Diagnostics ProfileTable Quest Diagnostics Production, Value, Price, Gross Margin 2015-2020Table Cancer Genetics ProfileTable Cancer Genetics Production, Value, Price, Gross Margin 2015-2020Table Invitae ProfileTable Invitae Production, Value, Price, Gross Margin 2015-2020Table PerkinElmer ProfileTable PerkinElmer Production, Value, Price, Gross Margin 2015-2020Table NeoGenomics ProfileTable NeoGenomics Production, Value, Price, Gross Margin 2015-2020Table Roche ProfileTable Roche Production, Value, Price, Gross Margin 2015-2020Table Iverson Genetics ProfileTable Iverson Genetics Production, Value, Price, Gross Margin 2015-2020Figure Global Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure Global Breast Cancer Predictive Genetic Testing Revenue ($) and Growth (2015-2020)Table Global Breast Cancer Predictive Genetic Testing Sales by Regions (2015-2020)Table Global Breast Cancer Predictive Genetic Testing Sales Market Share by Regions (2015-2020)Table Global Breast Cancer Predictive Genetic Testing Revenue ($) by Regions (2015-2020)Table Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Regions (2015-2020)Table Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Regions in 2015Table Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Regions in 2019Figure North America Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure Europe Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure Asia-Pacific Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure Middle East and Africa Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure South America Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure North America Breast Cancer Predictive Genetic Testing Revenue ($) and Growth (2015-2020)Table North America Breast Cancer Predictive Genetic Testing Sales by Countries (2015-2020)Table North America Breast Cancer Predictive Genetic Testing Sales Market Share by Countries (2015-2020)Figure North America Breast Cancer Predictive Genetic Testing Sales Market Share by Countries in 2015Figure North America Breast Cancer Predictive Genetic Testing Sales Market Share by Countries in 2019Table North America Breast Cancer Predictive Genetic Testing Revenue ($) by Countries (2015-2020)Table North America Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries (2015-2020)Figure North America Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries in 2015Figure North America Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries in 2019Figure United States Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure Canada Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure Mexico Breast Cancer Predictive Genetic Testing Sales and Growth (2015-2020)Figure Europe Breast Cancer Predictive Genetic Testing Revenue ($) Growth (2015-2020)Table Europe Breast Cancer Predictive Genetic Testing Sales by Countries (2015-2020)Table Europe Breast Cancer Predictive Genetic Testing Sales Market Share by Countries (2015-2020)Figure Europe Breast Cancer Predictive Genetic Testing Sales Market Share by Countries in 2015Figure Europe Breast Cancer Predictive Genetic Testing Sales Market Share by Countries in 2019Table Europe Breast Cancer Predictive Genetic Testing Revenue ($) by Countries (2015-2020)Table Europe Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries (2015-2020)Figure Europe Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries in 2015Figure Europe Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries in 2019Figure Germany Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure UK Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure France Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure Italy Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure Spain Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure Russia Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue ($) and Growth (2015-2020)Table Asia-Pacific Breast Cancer Predictive Genetic Testing Sales by Countries (2015-2020)Table Asia-Pacific Breast Cancer Predictive Genetic Testing Sales Market Share by Countries (2015-2020)Figure Asia-Pacific Breast Cancer Predictive Genetic Testing Sales Market Share by Countries in 2015Figure Asia-Pacific Breast Cancer Predictive Genetic Testing Sales Market Share by Countries in 2019Table Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue ($) by Countries (2015-2020)Table Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries (2015-2020)Figure Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries in 2015Figure Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries in 2019Figure China Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure Japan Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure South Korea Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure Australia Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure India Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure Southeast Asia Breast Cancer Predictive Genetic Testing Sales and Growth Rate (2015-2020)Figure Middle East and Africa Breast Cancer Predictive Genetic Testing Revenue ($) and Growth (2015-2020)continued

If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:Analytical Research Cognizance (ARC)is a trusted hub for research reports that critically renders accurate and statistical data for your business growth. Our extensive database of examined market reports places us amongst the best industry report firms. Our professionally equipped team further strengthens ARCs potential.ARC works with the mission of creating a platform where marketers can have access to informative, latest and well researched reports. To achieve this aim our experts tactically scrutinize every report that comes under their eye.

Contact Us:Ranjeet DengaleDirector SalesAnalytical Research Cognizance+1 (646) 403-4695, +91 90967 44448Email: [emailprotected]

Read the original here:
Impact Of Covid-19 on Breast Cancer Predictive Genetic Testing Market 2020 Industry Challenges, Business Overview and Forecast Research Study 2026 -...

New Jersey, United States Direct-To-Consumer (DTC) Genetic Testing Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026Presented byVerified Market Researchpresents a broad and elementary study of the market giving point by point coverage of the industry with its major market trends. The report contains the most important industry information while highlighting essential and valuable data. The report highlights inside and out research on market size, the development condition, advancement pattern, activity situation, and future advancement trends of the Direct-To-Consumer (DTC) Genetic Testing Market. It offers learning of various factors like Direct-To-Consumer (DTC) Genetic Testing Market growth, consumption volume, and business price structures throughout the forecast amount from 2020 to 2026. This research will also help makers and venture associations to higher handle the occasion course of the market.

Global Direct-to-Consumer (DTC) Genetic Testing Market was valued at USD 789.92 Million in 2018 and is projected to reach USD 2,361.12 Billion by 2026, growing at a CAGR of 14.59% from 2019 to 2026.

The report is furnished with the latest occurrences in the market owing to the COVID-19 pandemic. The pandemic has brought dynamic changes in the industry and the overall economic scenario. The report covers the impact analysis of the COVID-19 pandemic on market growth and revenue. The report also provides an extensive analysis of the current and future impact of the pandemic and an analysis of the post-COVID-19 scenario. This report includes data producers, including: shipping, pricing, revenues, gross profit, record interviews, business distribution, etc., this data helps consumers know about a better competitor.

Get | Download Sample Copy of this [emailprotected] https://www.verifiedmarketresearch.com/download-sample/?rid=25584&utm_source=BLN&utm_medium=003

The report provides an in-depth analysis of the competitive landscape and covers profiles of key players, along with their product portfolios and business strategies.

Key players of the market mentioned in the report are:

COVID-19 can influence the global economy in three ways: by directly influencing production and demand, by creating supply chain and market disruptions, and by having a financial impact on businesses and financial markets. The eruption of COVID-19 has implications for many aspects such as flight cancellations. Travel bans and quarantines; Restaurants closed; all Indoor Events restricted; over forty countries declared a state of emergency; massive supply chain slowdown; stock market volatility; falling business confidence, growing panic in the population and uncertainty about the future.

Competitive Landscape:

Direct-To-Consumer (DTC) Genetic Testing Market report highlights key players included in the market in order to render a comprehensive view of the competing players existing in the market. Company details, strategies, aptitude, history, cost analysis, and prevalent strategies. This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and Production by manufacturers during the forecast period of 2019 to 2026.

Regional analysis:

Geographically, the global Specialty Frozen Bakery market is divided into global regions like Europe, North America, Asia- Pacific, Middle East and Africa.

Ask For [emailprotected] https://www.verifiedmarketresearch.com/ask-for-discount/?rid=25584&utm_source=BLN&utm_medium=003

Highlights of the TOC of the Global Direct-To-Consumer (DTC) Genetic Testing Market Report:

Scope of Report:

This study analyses the growth of Direct-To-Consumer (DTC) Genetic Testing Market based on the present, past and futuristic data and will render entire information about the Internet Advertising industry to the market-leading industry players that will guide the direction of the Direct-To-Consumer (DTC) Genetic Testing Market through the forecast period. All of these players are analysed in detail to get details concerning their recent announcements and partnerships, product/services, investment strategies, and so on.

The key insights of the Direct-To-Consumer (DTC) Genetic Testing Market report:

Report customization:

Verified Market Research also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Purchase report with detailed assessment of the present and future impact of the COVID-19 pandemic on the industry: https://www.verifiedmarketresearch.com/checkout/?buyreport=25584&utm_source=BLN&utm_medium=003

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyse data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080

UK: +44 (203)-411-9686

APAC: +91 (902)-863-5784

US Toll-Free: +1 (800)-7821768

Email: [emailprotected]

Thank You for reading our report. The report is available for customization based on chapters or regions. Please get in touch with us to know more about customization options, and our team will ensure you get the report tailored according to your Requirements.

The rest is here:
Direct-To-Consumer (DTC) Genetic Testing Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2027 - Bulletin Line

Ancestry is stepping up its consumer DNA testingusing next-generation sequencing developed by Quest Diagnostics.

The family history and consumer genomics company is relaunching its AncestryHealth service with more advanced genetic testing technology to flag cutsomers' risk for developing certain inheritable diseases.

The sequencing-based tests replace Ancestry'sprevious microarray-based tests, the company said in arelease. The tests are physician-ordered, are not diagnostic and have not beenreviewed or approved by the Food and Drug Administration (FDA).

Top-Rated Mobile App for Health Insurance Members

Ziparis Mobile App is the smarter, easier, and better way for payers to engage members on the go and directly in the palm of their hands. Members can find the right doctors, receive notifications, send messages, view claims, track spending, talk to a nurse, download ID card, and more. Its ready to install and launch in a few months.

The advanced testing technology will help people better understand their risk for developing certain inherited health conditions such as heart disease, breast cancer, colon cancer and blood disorders, Ancestry said.

RELATED:Genealogy company Ancestry launches consumer genetic health testing as a rival to 23andMe

"When it comes to your health and your familys health, the more you know, the better, said Ron Park, M.D. executive vice presidentof health and DNA atAncestry in a statement.

"With the launch of AncestryHealth powered by NGS, we are helping people have access to more comprehensive data about their genetic risksand providing support with understanding those risksat a time when protecting our health is a major concern," Park said.

Ancestry, a company that uses DNA testing to give consumers information about their family history, moved into consumer genetic health testing as a rival to 23andMe last fall.

Ancestry, which owns AncestryDNA and launched in 2002, is one of the largest direct-to-consumer testing companies in the world with 24 billion records and more than 18 million people in its network.

The company saidits relaunched health offeringmarks a dramatic shift in consumer-initiated genetic testing, which, for the last decade, has largely been based on microarray technology.

Because NGS technology can access orders of magnitude more of the genome, including challenging-to-sequence variants, the NGS technology that powers AncestryHealth does a better job of determining if someone is at greater risk for some of the most common inherited health conditions, according to Quest Diagnostics.

RELATED:JPM20: Health technology company Color scores $75M funding round to scale its infrastructure

In comparison to the more widely-used microarray-based testing technology, AncestryHealth powered by next-generation sequencing achieves about 80% to 90% detection of inherited risk for specific health conditions, according to the company.

The use of the technology can lead to higher detection rates for the risk of breast and ovarian cancer, for example, at arate four times higher than most microarray-based tests, Ancestry said.

"As the market leader in consumer genomics for more than a decade, we are proud to make an important leap forward in democratizing access to comprehensive genetic health risk detection, said Margo Georgiadis, president and chief executive officer at Ancestry.

AncestryHealth will provide customers with remote access to genetic counselors in partnership withPWNHealth, an independent network of board-certified genetic counselors, geneticistsand physicians, as well as access to a clinical lab report to share with their doctors.

These services will help consumers better understand their results and make more informed choices, the company said.

Ancestry also aims to create a downloadable family health history record that can be delivered to clinicians and used to help fill out medical forms.

RELATED:Ancestry's Catherine Ball on why the genealogy company just gave UpToDate a $1M grant

Quest developed a faster and cheaper way to perform next generation sequencingto power AncestryHealth, the company said.

"This improvement in automating next generation sequencing will enable genetic screening faster and at much lower cost, and could have profound implications for healthcare in the future, truly empowering better health through actionable insights for millions of people who want to know more about their health risks," saidSteve Rusckowski, Quest Diagnostics chairman, chief executive and president in a statement.

"It wasn't long ago that genetic sequencing took months and cost thousands of dollars. Quest's proprietary innovation enables sequencing insights in a fraction of the time at a fraction of the cost," Rusckowski said.

AncestryHealths kit will be available in 47 states, not including New York, New Jersey and Rhode Island, for $179.

Read the original post:
Ancestry rolls out more advanced DNA testing to flag risk of heart disease, breast cancer - FierceHealthcare

This recent study of the Rare Disease Genetic Testing market contains a thorough evaluation of this industry vertical. According to the report, the market will record decent returns by the end of the forecast period, while registering a substantial growth rate throughout this duration.

Growth Report on Rare Disease Genetic Testing Market size | Industry Segment by Applications (Research Laboratories and CROs, Diagnostic Laboratories, Hospitals and Clinics and Others), by Type (Next-Generation Sequencing (NGS), Array Technology, PCR-based Testing, Fluorescence in Situ Hybridization (FISH), Sanger Sequencing, Karyotyping and Others), Regional Outlook, Market Demand, Latest Trends, Rare Disease Genetic Testing Industry Share, Research Growth Forecast & Revenue by Manufacturers, The Leading Company Profiles, Growth Forecasts 2025.

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/161113

The report uncovers important insights of the Rare Disease Genetic Testing market and includes projections with respect to revenue, industry size, and sales volumes over the study period. Additionally, the Rare Disease Genetic Testing market report provides detailed information regarding industry segmentations as well as the driving factors that will propel the profitability graph of the industry.

This report studies the Rare Disease Genetic Testing market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Rare Disease Genetic Testing industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Rare Disease Genetic Testing industry.

A glimpse of the Rare Disease Genetic Testing market with respect to the geographical landscape:

Competitive Landscape and Rare Disease Genetic Testing Market Share Analysis:

Rare Disease Genetic Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Rare Disease Genetic Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Rare Disease Genetic Testing sales, revenue and market share for each player covered in this report.

Market segmentation: Rare Disease Genetic Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Other important inclusions of the Rare Disease Genetic Testing market are listed below:

Research objectives:

Questions Answered by the Report:

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/161113

Continue reading here:
Rare Disease Genetic Testing Market 2020; Region Wise Analysis of Top Players in Market and its Types and Application - Express Journal

News

The RACGP is offering training in carrier screening, covering the knowledge and skills required to initiate the important conversation with patients.

Around one in 200 babies is born with an inherited rare condition.These conditions account for 20% of infant mortality. And while they are individually rare, people on average are carriers of two severe autosomal recessive conditions.While genetic carrier screening has traditionally only been offered to those with a family history and partners of identified carriers, as well as those of a particular ethnicity, that has since changed.National guidelines now recommend all women or couples planning a family, or who are in the first trimester of pregnancy, be given the option in order to understand their risk.To help raise awareness among GPs and other healthcare professionals, the RACGP has launched the Beware the Rare education campaign.Professor Jon Emery is a GP and adviser for the campaign. He says the earlier carrier screening is carried out, the better.This provides couples an opportunity to plan their reproductive choices more into the future, he told newsGP.Part of this campaign is around raising these issues when couples are beginning to plan a pregnancy, so preconception, because the reproductive choices are somewhat greater at that point.But, of course, we know a lot of people will often get pregnant without them necessarily formally planning it, and so the other time to be having these discussions is early on in the first trimester of the pregnancy, and offering the couple the opportunity to consider whether they want to have carrier screening to see if theyre at risk of having an affected child.Modes of testing including either a mouth swab or blood test.There are currently three types of carrier screening panels available:

Professor Jon Emerysays the earlier carrier screening is carried out, the better.Medicare does not currently provide rebates for most genetic tests, which cost patients hundreds of dollars.A research program called Mackenzies Mission is setting out to change that, however, thanks in large part to Rachael Casella and her husband.After losing their seven-month-old daughter Mackenzie in 2017 to spinal muscular atrophy type 1, a genetic neuromuscular disorder, the couple lobbied the Federal Government to make genetic testing routine and covered by Medicare.In response, $20 million was committed from the Medical Research Future Fund to a three-year pilot study that will set out to screen 10,000 Australian couples for around 750 genetic conditions.The expanded panel test costs between $600 and $900. So its not a cheap test, Professor Emery said.Mackenzies Mission will hopefully provide new evidence around the accessibility of this test, and inform future decisions around whether these tests eventually become available through the Federal Government.But I think we are increasingly going to see a greater role for genomic tests, both in terms of reproductive choices, but also in terms of predicting the way we respond to drugs and predicting our risks of a range of common diseases so that we can tailor our prevention more.The RACGP is hosting a free webinar, Fertility, pregnancy and genetic testing options, on Wednesday 5 August, 7.00pm8.00 pm (AEST). The event attracts two CPD points. Visit the RACGP website to register.GPs can access information and resources on genetic carrier screening through the RACGPs education campaign website. There is also an accredited training module worth two CPD points.Log in below to join the conversation.

genetic carrier screening preconception pregnancy reproductive choice

The rest is here:
newsGP - Genetic carrier screening: What GPs need to know - RACGP

Global At-home Genetic Testing Market Report 2019 Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global At-home Genetic Testing industry.

The report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

There are 4 key segments covered in this report: competitor segment, product type segment, end use/application segment and geography segment.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2601844&source=atm

For competitor segment, the report includes global key players of At-home Genetic Testing as well as some small players.

The key players covered in this study23andMeMyHeritageLabCorpMyriad GeneticsAncestry.comQuest DiagnosticsGene By GeneDNA Diagnostics CenterInvitaeIntelliGeneticsAmbry GeneticsLiving DNAEasyDNAPathway GenomicsCentrillion TechnologyXcodeColor GenomicsAnglia DNA ServicesAfrican AncestryCanadian DNA ServicesDNA Family CheckAlpha BiolaboratoriesTest Me DNA23 MofangGenetic HealthDNA Services of AmericaShuwen Health SciencesMapmygenomeFull Genomes

Market segment by Type, the product can be split intoDiagnostic ScreeningPGDRelationship testingMarket segment by Application, split intoOnlineOffline

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaJapanSoutheast AsiaIndiaCentral & South America

The study objectives of this report are:To analyze global At-home Genetic Testing status, future forecast, growth opportunity, key market and key players.To present the At-home Genetic Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of At-home Genetic Testing are as follows:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year 2020 to 2026For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2601844&licType=S&source=atm

Important Key questions answered in At-home Genetic Testing market report:

What will the market growth rate, Overview, and Analysis by Type of At-home Genetic Testing in 2024?

What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in At-home Genetic Testing market?

What is Dynamics, This Overview Includes Analysis of Scope and price analysis of top Manufacturers Profiles?

Who Are Opportunities, Risk and Driving Force of At-home Genetic Testing market? Knows Upstream Raw Materials Sourcing and Downstream Buyers.

Who are the key manufacturers in space? Business Overview by Type, Applications, Gross Margin, and Market Share

What are the opportunities and threats faced by manufacturers in the global market?

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2601844&source=atm

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe At-home Genetic Testing product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of At-home Genetic Testing , with price, sales, revenue and global market share of At-home Genetic Testing in 2019 and 2015.

Chapter 3, the At-home Genetic Testing competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the At-home Genetic Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2019 to 2025.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2019 to 2025.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2019 to 2025.

Chapter 12, At-home Genetic Testing market forecast, by regions, type and application, with sales and revenue, from 2019 to 2025.

Chapter 13, 14 and 15, to describe At-home Genetic Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Visit link:
At-home Genetic Testing Market Research by Key players, Type and Application, Future Growth to 2026 - Owned

Overview Of Breast Cancer Predictive Genetic Testing Industry 2020-2025:

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

The Breast Cancer Predictive Genetic Testing Market analysis summary by Reports Insights is a thorough study of the current trends leading to this vertical trend in various regions. Research summarizes important details related to market share, market size, applications, statistics and sales. In addition, this study emphasizes thorough competition analysis on market prospects, especially growth strategies that market experts claim.

Breast Cancer Predictive Genetic Testing Market competition by top manufacturers as follow: , Roche, Thermo Fisher Scientific, PerkinElmer, Quest Diagnostics, Myriad Genetics, Iverson Genetics, Cancer Genetics, OncoCyte Corporation, NeoGenomics, Invitae

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/114139

The global Breast Cancer Predictive Genetic Testing market has been segmented on the basis of technology, product type, application, distribution channel, end-user, and industry vertical, along with the geography, delivering valuable insights.

The Type Coverage in the Market are: High Penetrant GenesIntermediate Penetrant GenesLow Penetrant Genes

Market Segment by Applications, covers:HospitalsClinicsOthers

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaRest of Asia PacificCentral & South AmericaMiddle East & Africa

Major factors covered in the report:

To get this report at a profitable rate.: https://reportsinsights.com/discount/114139

The analysis objectives of the report are:

Access full Report Description, TOC, Table of Figure, Chart, [emailprotected] https://reportsinsights.com/industry-forecast/Breast-Cancer-Predictive-Genetic-Testing-Market-114139

About US:

Reports Insights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

Contact US:

:(US) +1-214-272-0234

:(APAC) +91-7972263819

Email:[emailprotected]

Sales:[emailprotected]

Go here to read the rest:
New Comprehensive Report on Breast Cancer Predictive Genetic Testing Market to Witness an Outstanding Growth during 2020 2025 with Top Players Like...

Predictive Genetic Testing And Consumer/Wellness Genomics Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis.

Predictive Genetic Testing And Consumer/Wellness Genomics Market is growing at a High CAGR during the forecast period 2020-2026. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market.

Get Sample Copy (Including FULL TOC, Graphs and Tables) of this report:

https://www.a2zmarketresearch.com/sample?reportId=115261

Top Key Players Profiled in This Report:

Illumina, BGI, Genesis Genetics, Myriad Genetics, 23andMe, Inc, Color Genomics Inc, Pathway Genomics, ARUP Laboratories

The key questions answered in this report:

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Predictive Genetic Testing And Consumer/Wellness Genomics market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Predictive Genetic Testing And Consumer/Wellness Genomics markets trajectory between forecast periods.

Get up to 20% Discount on this Premium Report @:

https://www.a2zmarketresearch.com/discount?reportId=115261

Reasons for buying this report:

Table of Contents:

Global Predictive Genetic Testing And Consumer/Wellness Genomics Market Research Report

Chapter 1 Predictive Genetic Testing And Consumer/Wellness Genomics Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Predictive Genetic Testing And Consumer/Wellness Genomics Market Forecast

Buy Exclusive Report @:

https://www.a2zmarketresearch.com/buy?reportId=115261

If you have any special requirements, please let us know and we will offer you the report as you want.

Go here to read the rest:
Comprehensive Report on Predictive Genetic Testing And Consumer/Wellness Genomics Market 2020 | Size, Growth, Demand, Opportunities & Forecast To...

The recent research report titled Global (Covid-19 Impact) Breast Cancer Predictive Genetic Testing Sales Market (Sales,Revenue and competitors Analysis of Major Market) from 2014-2026 has been added in the kandjmarketresearch.com database. This market report is a valuable source of insightful data for business strategists. It offers the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The report explores the current outlook in global and key regions from the perspective of players, countries, product types, and end industries. This Breast Cancer Predictive Genetic Testing Market study provides comprehensive data that enhances the understanding, scope, and application of this report.

Market Overview

Indispensable insights of the Breast Cancer Predictive Genetic Testing market are elaborated in the report. The core objective of the report is to deliver reliable and concrete information about the Breast Cancer Predictive Genetic Testing market that can assist the businessmen to make rational decisions. The expected CAGR and valuation of the Breast Cancer Predictive Genetic Testing market are mentioned in the report. Proficient analysts have studied the market for the evaluation year of 2020 to 2026. Significant factors that are likely to promote the growth of the Breast Cancer Predictive Genetic Testing market and possible constraints of the market are elaborated in this market research report. Potential growth scopes are also elaborated in the report. The Breast Cancer Predictive Genetic Testing market studied in segments to provide information about the same market that encompasses crucial aspects of the Breast Cancer Predictive Genetic Testing industry or market. The regional progress of the Breast Cancer Predictive Genetic Testing market is studied under the regional outlook section. A lucid understanding of the transforming competitive landscape of the market can assist investors in several ways. North America, Europe, and APAC are key regions across which is in the studied. For the Rest of the World (RoW), the Breast Cancer Predictive Genetic Testing market is analyzed across China, USA, Europe, Japan, Korea, India, Southeast Asia and South America.

The latest report includes Impact of Coronavirus(Covid-19) on the Breast Cancer Predictive Genetic Testing Industry, it includes on Industry Upstream, Industry Downstream, Industry Channels, Industry Competition, and finally on Industry Employment.

The Final Report Will Include the Impact of COVID 19 Analyses in This Industry. For Sample Report & Graphs & Charts @: https://www.kandjmarketresearch.com/sample-request/403987

Key Players overview

Credible sources, such as surveys, financial magazines, and whitepapers are referred for listing key players of the Breast Cancer Predictive Genetic Testing market. However, interviews with well-known personalities, such as CEOs, COO, and entrepreneurs are accepted as the most effective tool to prepare contribution of key players towards the growth of the Breast Cancer Predictive Genetic Testing market. Past aspects and current trends of market players in the Breast Cancer Predictive Genetic Testing market are elaborated in the report. The financial status of market players and their contributions are discussed in the report that offers a clear understanding to the investors and aids them in making rational decisions.

Global Breast Cancer Predictive Genetic Testing market competition by top manufacturers/players, with Breast Cancer Predictive Genetic Testing sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including:

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into:-

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Breast Cancer Predictive Genetic Testing for each application, including:-

Ask for Discount @https://www.kandjmarketresearch.com/discount/403987

This report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Breast Cancer Predictive Genetic Testing for these regions, from 2014 to 2026 (forecast), covering:-

Research Methodology

Research methodologies utilized in cooking the report are rigorous and fail-safe. The robust scoring process is employed to deliver an objective and accurate overview of the Breast Cancer Predictive Genetic Testing market. Modern research techniques used to offer vivid qualitative and qualitative findings of the Breast Cancer Predictive Genetic Testing industry. The powerful research techniques used to study the Breast Cancer Predictive Genetic Testing market aid in the collection of evidence and data to deliver precise report. The market research firm uses various tools for the collection of information for primary and secondary analysis of the Breast Cancer Predictive Genetic Testing market to prepare a report that can be an ultimate guide for investors. Top-down and bottom-up approaches maintained for the assessment of the Breast Cancer Predictive Genetic Testing market for the forecast years ensures high-quality and valuable insights into the Breast Cancer Predictive Genetic Testing market.

Key Highlights of TOC:

And List of Tables and Figures.

Read More Detailed Information regarding Breast Cancer Predictive Genetic Testing Industry with Covid-19 Updates @ https://www.kandjmarketresearch.com/reports/403987-global-covid-19-impactbreast-cancer-predictive-genetic-testing-sales-market-salesrevenue-and-competitors-analysis-of-major-market-from-2014-2026

About Us:

Kandjmarketresearch.com is part of the KnowledgeNJournals Research Firm which provides premium progressive market research reports, statistical surveying, analysis & forecast data for industries and governments from hundreds of publishers around the world. We have almost all top publishers reports in our collection to provide you with instant online access to the worlds most complete and fresh database on a Daily Basis. We are at KandJ Market Research are inspired to help our clients grow by providing appropriate business insight with our huge market intelligence source.

If you have any special requirements for the report, please let us know and we will offer you a customized report on separate regional or country-level reports.

Contact us:

KandJ Market Research

(Part of KnowledgeNJournals Research)

E-mail: [emailprotected]

Website: https://www.kandjmarketresearch.com

(USA): +1 661 636 6162 | (IND): +91 932 580 2062

Continued here:
Breast Cancer Predictive Genetic Testing Market 2020-2026 Analysis, Trends And Forecasts Research Report - Owned

The prime objective of GlobalNewborn and Prenatal Genetic Testing Market report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

Impact of Covid-19 in Newborn and Prenatal Genetic Testing Market: Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Newborn and Prenatal Genetic Testing market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Download FREE Sample Copy of Newborn and Prenatal Genetic Testing Report @https://www.crediblemarkets.com/sample-request/newborn-and-prenatal-genetic-testing-market-51974

By Market Players:Perkin ElmerAriosa DiagnosticsAgilent Technologies, Inc.Verinata HealthIllumina, Inc.Sequenom, Inc.CapitalBio MedLabNatera, Inc.Bio-Rad Laboratories, Inc.BGI

By TypePCRFISHaCGHNIPTMSS

By ApplicationHospitalClinicOthers

Geographically, the detailed analysis of consumption, revenue, and market share and growth rate, historic and forecast of the following regions:

United States, Canada, Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium, China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia, Brazil, Mexico, Argentina, Columbia, Chile, Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of the World

Enquiry before buying this report @ https://www.crediblemarkets.com/enquire-request/newborn-and-prenatal-genetic-testing-market-51974

Some Points from Table of Content

Covid-19 Impact on Global Newborn and Prenatal Genetic Testing Industry Research Report 2020 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2026

Chapter 1 Report OverviewChapter 2 Global Newborn and Prenatal Genetic Testing Market Trends and Growth StrategyChapter 3 Global Newborn and Prenatal Genetic Testing Market Players ProfilesChapter 4 Global Newborn and Prenatal Genetic Testing Market Competition by Market PlayersChapter 5 Global Newborn and Prenatal Genetic Testing Production by Regions (2015-2020)Chapter 6 Global Newborn and Prenatal Genetic Testing Consumption by Region (2015-2020)Chapter 7 Global Newborn and Prenatal Genetic Testing Production Forecast by Regions (2021-2026)Chapter 8 Global Newborn and Prenatal Genetic Testing Consumption Forecast by Regions (2021-2026)Chapter 9 Global Newborn and Prenatal Genetic Testing Sales by Type (2015-2026)Chapter 10 Global Newborn and Prenatal Genetic Testing Consumption by Application (2015-2026)Chapter 11 Global Newborn and Prenatal Genetic Testing Manufacturing Cost AnalysisChapter 12 Global Newborn and Prenatal Genetic Testing Marketing Channel, Distributors, Customers and Supply ChainChapter 13 Analysts Viewpoints/ConclusionsChapter 14 Disclaimer

Grab Maximum Discount on Newborn and Prenatal Genetic Testing Market Research Report @https://www.crediblemarkets.com/discount-request/newborn-and-prenatal-genetic-testing-market-51974

Points Covered in The Report

About Credible Markets

Credible Markets has emerged as a dependable source for the market research needs of businesses within a quick time span. We have collaborated with leading publishers of market intelligence and the coverage of our reports reserve spans all the key industry verticals and thousands of micro markets. The massive repository allows our clients to pick from recently published reports from a range of publishers that also provide extensive regional and country-wise analysis. Moreover, pre-booked research reports are among our top offerings.

Contact Us

Credible Markets Analytics

99 Wall Street 2124 New York, NY 10005

US Contact No: +1(929)-450-2887

Email: [emailprotected]

Ask for customization @https://www.crediblemarkets.com/custom-research

The rest is here:
Newborn and Prenatal Genetic Testing Market 2020 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2026 - Bulletin Line